| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | eye development | CYP1A1 CPAMD8 MYO7A LAMA1 ARID1A NPHP4 MAP3K1 LHX2 KMT2C GNB1 PTF1A PRPH2 ZHX2 CRX PPP2R3A TENM3 RP1 PCNT | 1.79e-05 | 480 | 244 | 18 | GO:0001654 |
| GeneOntologyBiologicalProcess | visual system development | CYP1A1 CPAMD8 MYO7A LAMA1 ARID1A NPHP4 MAP3K1 LHX2 KMT2C GNB1 PTF1A PRPH2 ZHX2 CRX PPP2R3A TENM3 RP1 PCNT | 1.94e-05 | 483 | 244 | 18 | GO:0150063 |
| GeneOntologyBiologicalProcess | sensory system development | CYP1A1 CPAMD8 MYO7A LAMA1 ARID1A NPHP4 MAP3K1 LHX2 KMT2C GNB1 PTF1A PRPH2 ZHX2 CRX PPP2R3A TENM3 RP1 PCNT | 2.41e-05 | 491 | 244 | 18 | GO:0048880 |
| GeneOntologyBiologicalProcess | regulation of Toll signaling pathway | 3.19e-05 | 6 | 244 | 3 | GO:0008592 | |
| GeneOntologyBiologicalProcess | sensory organ development | CYP1A1 CPAMD8 EYA4 MYO7A LAMA1 ADGRV1 ARID1A NPHP4 MAP3K1 LHX2 KMT2C GSDME GNB1 PTF1A PRPH2 REST ZHX2 CRX PPP2R3A TENM3 RP1 PCNT | 6.03e-05 | 730 | 244 | 22 | GO:0007423 |
| GeneOntologyBiologicalProcess | positive regulation of vascular associated smooth muscle cell migration | 6.21e-05 | 36 | 244 | 5 | GO:1904754 | |
| GeneOntologyCellularComponent | asymmetric synapse | ATP7A RPS3 ANKS1B MGLL LRRC4 SORT1 SYN1 DGCR8 KALRN CAMK2G PKP4 LRP1 ARHGEF2 CPEB1 KLHL17 BAALC | 1.98e-04 | 477 | 248 | 16 | GO:0032279 |
| GeneOntologyCellularComponent | dendrite | ATP7A RPS3 ANKS1B LMTK3 LRRC4 CHRNA4 SORT1 SACS SYN1 IGSF9 OSBP2 BRD1 GNB1 PREX1 DIP2B DYRK1A CPE PEX5L LRP1 ARHGEF2 PCDH8 CPEB1 KLHL17 | 2.43e-04 | 858 | 248 | 23 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | ATP7A RPS3 ANKS1B LMTK3 LRRC4 CHRNA4 SORT1 SACS SYN1 IGSF9 OSBP2 BRD1 GNB1 PREX1 DIP2B DYRK1A CPE PEX5L LRP1 ARHGEF2 PCDH8 CPEB1 KLHL17 | 2.51e-04 | 860 | 248 | 23 | GO:0097447 |
| GeneOntologyCellularComponent | somatodendritic compartment | ATP7A RPS3 ANKS1B LMTK3 LRRC4 CHRNA4 SORT1 SACS ACAN SYN1 IGSF9 OSBP2 BRD1 GNB1 PREX1 DIP2B KALRN CAMK2D DYRK1A CASP4 CPE PEX5L SPTBN4 LRP1 ARHGEF2 PCDH8 CPEB1 SORL1 KLHL17 | 3.24e-04 | 1228 | 248 | 29 | GO:0036477 |
| GeneOntologyCellularComponent | photoreceptor inner segment | 3.30e-04 | 78 | 248 | 6 | GO:0001917 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | ATP7A RPS3 ANKS1B MGLL LRRC4 SORT1 SYN1 DGCR8 KALRN CAMK2G PKP4 LRP1 ARHGEF2 CPEB1 KLHL17 BAALC | 5.45e-04 | 523 | 248 | 16 | GO:0098984 |
| Domain | RIBUL_P_3_EPIMER_1 | 1.73e-04 | 2 | 246 | 2 | PS01085 | |
| Domain | Ribul_P_3_epim-like | 1.73e-04 | 2 | 246 | 2 | IPR000056 | |
| Domain | Ribul_P_3_epim | 1.73e-04 | 2 | 246 | 2 | PF00834 | |
| Domain | Phosphofurin_acidic_CS-1 | 1.73e-04 | 2 | 246 | 2 | IPR019381 | |
| Domain | Pacs-1 | 1.73e-04 | 2 | 246 | 2 | PF10254 | |
| Domain | ANKS1 | 1.73e-04 | 2 | 246 | 2 | IPR033635 | |
| Domain | Ribul_P_3_epim | 1.73e-04 | 2 | 246 | 2 | IPR026019 | |
| Domain | 6-blade_b-propeller_TolB-like | 3.36e-04 | 46 | 246 | 5 | IPR011042 | |
| Domain | - | WDR54 SORT1 EML5 DCAF8L1 GNB1 PLXNB3 SEMA6C DYNC2I1 LLGL1 WDHD1 WDR6 CORO6 SON | 4.97e-04 | 333 | 246 | 13 | 2.130.10.10 |
| Domain | RNA_pol_Rpb1_2 | 5.14e-04 | 3 | 246 | 2 | PF00623 | |
| Domain | - | 5.14e-04 | 3 | 246 | 2 | 1.10.10.430 | |
| Domain | RNA_pol_Rpb1_1 | 5.14e-04 | 3 | 246 | 2 | PF04997 | |
| Domain | RNA_pol_Rpb1_5 | 5.14e-04 | 3 | 246 | 2 | PF04998 | |
| Domain | RNA_pol_Rpb1_3 | 5.14e-04 | 3 | 246 | 2 | PF04983 | |
| Domain | RNA_pol_Rpb1_4 | 5.14e-04 | 3 | 246 | 2 | PF05000 | |
| Domain | RNA_pol_Rpb1_4 | 5.14e-04 | 3 | 246 | 2 | IPR007083 | |
| Domain | RNA_pol_Rpb1_5 | 5.14e-04 | 3 | 246 | 2 | IPR007081 | |
| Domain | RNA_pol_Rpb1_1 | 5.14e-04 | 3 | 246 | 2 | IPR007080 | |
| Domain | RNA_pol_Rpb1_3 | 5.14e-04 | 3 | 246 | 2 | IPR007066 | |
| Domain | Pellino | 5.14e-04 | 3 | 246 | 2 | PF04710 | |
| Domain | PP2C_C | 5.14e-04 | 3 | 246 | 2 | IPR012911 | |
| Domain | RNA_pol_asu | 5.14e-04 | 3 | 246 | 2 | IPR000722 | |
| Domain | Niban-like | 5.14e-04 | 3 | 246 | 2 | IPR026088 | |
| Domain | RNA_pol_N | 5.14e-04 | 3 | 246 | 2 | IPR006592 | |
| Domain | PP2C_C | 5.14e-04 | 3 | 246 | 2 | PF07830 | |
| Domain | RibuloseP-bd_barrel | 5.14e-04 | 3 | 246 | 2 | IPR011060 | |
| Domain | RPOLA_N | 5.14e-04 | 3 | 246 | 2 | SM00663 | |
| Domain | Pellino_fam | 5.14e-04 | 3 | 246 | 2 | IPR006800 | |
| Domain | WD40/YVTN_repeat-like_dom | WDR54 SORT1 EML5 DCAF8L1 GNB1 PLXNB3 SEMA6C DYNC2I1 LLGL1 WDHD1 WDR6 CORO6 SON | 5.26e-04 | 335 | 246 | 13 | IPR015943 |
| Domain | - | MYO7A OBSCN ANKS1B PTPN13 OSBP2 PREX1 ANKS1A RANBP2 KALRN ASAP3 SHC1 NIBAN2 SPTBN4 ARHGEF2 | 7.17e-04 | 391 | 246 | 14 | 2.30.29.30 |
| Domain | Tox-GHH_dom | 1.02e-03 | 4 | 246 | 2 | IPR028916 | |
| Domain | G8 | 1.02e-03 | 4 | 246 | 2 | PS51484 | |
| Domain | Tox-GHH | 1.02e-03 | 4 | 246 | 2 | PF15636 | |
| Domain | Ten_N | 1.02e-03 | 4 | 246 | 2 | PF06484 | |
| Domain | G8 | 1.02e-03 | 4 | 246 | 2 | PF10162 | |
| Domain | TENEURIN_N | 1.02e-03 | 4 | 246 | 2 | PS51361 | |
| Domain | CaMKII_AD | 1.02e-03 | 4 | 246 | 2 | PF08332 | |
| Domain | G8_domain | 1.02e-03 | 4 | 246 | 2 | IPR019316 | |
| Domain | G8 | 1.02e-03 | 4 | 246 | 2 | SM01225 | |
| Domain | Ca/CaM-dep_prot_kinase-assoc | 1.02e-03 | 4 | 246 | 2 | IPR013543 | |
| Domain | Ten_N | 1.02e-03 | 4 | 246 | 2 | IPR009471 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | GBF1 MYO7A OBSCN RAP1GAP2 ARID1A NPHP4 TBC1D9 KMT2C ZNRF3 KCNH2 RAB43 MCM3AP PKD1 SEC16A RIC8A METTL27 PREX1 SEMA6C FRAS1 NRF1 KALRN MTHFD1L POLR2A SHC1 DYRK1A HUWE1 NISCH PDCD11 ARHGEF2 ZNF839 CABIN1 AHNAK2 PCNT KLHL17 | 1.73e-12 | 1105 | 254 | 34 | 35748872 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SPTLC3 RNF130 CPAMD8 MBTPS1 SEPTIN9 OBSCN MGLL ANKMY1 ADGRV1 ARID1A TTF1 DOCK5 KMT2C PTPN13 IGSF9 CENATAC MMP16 ANKS1A DIP2B SLC9A8 POLR1A NRF1 CXXC5 DYNC2I1 RNF213 CHD9 HUWE1 ZHX2 PLBD2 SPTBN4 PACS1 PPP2R3A GTF2H2 LRP1 CNDP2 ZFHX3 LIMCH1 ZNF839 PCNT | 4.87e-12 | 1489 | 254 | 39 | 28611215 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HK2 RPS3 SEPTIN9 PSMB5 BMS1 PSMD2 RCC1 PRPF6 ARID1A MCM3AP MIF SEC16A AP1M1 DLST RIC8A ALDH9A1 GMPPB DHX29 RANBP2 POLR1A MTHFD1L CAMK2D CAMK2G POLR2A PKP4 HUWE1 RUNX1 IPO4 ELP3 LLGL1 WDR6 PDCD11 ARHGEF2 SON AHNAK2 | 9.57e-11 | 1353 | 254 | 35 | 29467282 |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | CAND2 LAMA1 PSMB5 PSMD2 PTPN13 NUDT19 CAMK2D CAMK2G POLR2A DYRK1A HUWE1 IPO4 LLGL1 WDHD1 WDR6 MTR ARHGEF2 | 1.97e-10 | 313 | 254 | 17 | 38270169 |
| Pubmed | ANKS1B LMTK3 SEC16A SYN1 GNB1 ANKS1A DIP2B CACNB1 RANBP2 KALRN CAMK2D CAMK2G PKP4 DYRK1A DPYSL4 HUWE1 IPO4 PEX5L SPTBN4 N4BP2 NISCH LRP1 LIMCH1 ARHGEF2 CABIN1 PCDH8 MTSS2 PCNT | 6.56e-10 | 963 | 254 | 28 | 28671696 | |
| Pubmed | DOCK4 MBTPS1 ZFYVE16 AVL9 SEPTIN9 RAP1GAP2 DENND4B MCM3AP SEC16A PACS2 PLXNB3 FRAS1 ZHX2 TENM3 NISCH LIMCH1 SON PCNT | 1.54e-09 | 407 | 254 | 18 | 12693553 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | CAND2 RPS3 SEPTIN9 RCC1 PRPF6 AP1M1 RIC8A GNB1 ALDH9A1 GMPPB DHX29 DNAH8 NCAPD3 RANBP2 POLR1A MTHFD1L POLR2A HUWE1 IPO4 WDHD1 SEC11A PDCD11 SON | 2.77e-09 | 704 | 254 | 23 | 29955894 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | GBF1 CAND2 HK2 ACADSB RPS3 PSMB5 PSMD2 PRPF6 DDX11 SEC16A SFXN2 AP1M1 GNB1 GMPPB NCAPD3 RANBP2 SLC25A21 POLR1A MTHFD1L CAMK2D CAMK2G POLR2A HUWE1 IPO4 ELP3 PPM1A GTF2H2 WDR6 SEC11A MTR | 1.46e-08 | 1257 | 254 | 30 | 37317656 |
| Pubmed | ATP7A CAND2 ACADSB BMS1 RCC1 PRPF6 CEMIP2 TTLL12 PTPN13 SACS DLST ALDH9A1 ZNHIT2 DHX29 NUDT19 FRAS1 MTHFD1L PKP4 NIBAN2 VARS2 IPO4 TFCP2 LLGL1 LMAN1 WDR6 N4BP2 MACO1 NISCH MTR CNDP2 PDCD11 CHID1 PCNT | 1.51e-08 | 1487 | 254 | 33 | 33957083 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | EYA4 GBF1 CAND2 ZFYVE16 PSMB5 BMS1 PSMD2 LANCL2 SEC16A ALDH9A1 DHX29 DIP2B NCAPD3 RANBP2 MTHFD1L SHC1 HUWE1 IPO4 ELP3 LMAN1 WDR6 MACO1 SEC11A LRP1 CDC25B SORL1 | 1.58e-08 | 974 | 254 | 26 | 28675297 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | GBF1 RPS3 SEPTIN9 RCC1 TBC1D9 SEC16A PACS2 DHX29 ANKS1A DIP2B NCAPD3 RANBP2 POLR2A NIBAN2 REST HUWE1 RUNX1 PACS1 WDHD1 TRAPPC10 LIMCH1 ARHGEF2 SON | 1.61e-08 | 774 | 254 | 23 | 15302935 |
| Pubmed | EYA4 ZFYVE16 BMS1 PSMD2 RCC1 ARID1A CEMIP2 SORT1 PTPN13 SEC16A RANBP2 POLR2A PKP4 SHC1 RNF213 NIBAN2 HUWE1 ELP3 PPM1A PPM1B PACS1 PPP2R3A LMAN1 MACO1 ARHGEF2 CDC25B PCNT | 1.75e-08 | 1049 | 254 | 27 | 27880917 | |
| Pubmed | ANKS1B RAP1GAP2 PSMD2 ARID1A LRRC4 TTLL12 GDAP1L1 PTPN13 SACS PKD1 LRRN2 DLST DGCR8 GNB1 PREX1 CNOT2 PLXNB3 ALPL KALRN CXXC5 DYRK1A DYNC2I1 CHD9 HUWE1 RUNX1 SPTBN4 NISCH LRP1 CABIN1 PCNT | 2.39e-08 | 1285 | 254 | 30 | 35914814 | |
| Pubmed | CAND2 HK2 ACADSB SORT1 SFXN2 RIC8A MTO1 GNB1 GMPPB NCAPD3 RANBP2 MTHFD1L CAMK2D CAMK2G DYRK1A HUWE1 IPO4 PLBD2 MTR SON | 2.65e-08 | 606 | 254 | 20 | 36538041 | |
| Pubmed | EYA4 SAMD9 HK2 PSMB5 CEMIP2 TTLL12 DOCK5 AP1M1 DIP2B NCAPD3 FRAS1 PKP4 PACS1 LLGL1 WDR6 NISCH MTR ARHGEF2 CDC25B SORL1 | 8.27e-08 | 650 | 254 | 20 | 38777146 | |
| Pubmed | CAND2 HK2 ACADSB PSMB5 BMS1 PSMD2 RCC1 PRPF6 SORT1 LHX2 DLST GNB1 DHX29 ALPL NUDT19 NCAPD3 RANBP2 MTHFD1L RNF213 HUWE1 IPO4 WDR6 MACO1 SCARB2 TRAPPC10 PDCD11 LIMCH1 ARHGEF2 CABIN1 MX1 AHNAK2 | 8.45e-08 | 1440 | 254 | 31 | 30833792 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | GBF1 SEPTIN9 PSMB5 BMS1 PSMD2 PRPF6 ARID1A SEC16A CPNE1 AP1M1 DLST GNB1 GMPPB DHX29 RANBP2 MTHFD1L CAMK2D SHC1 RNF213 DPYSL4 NIBAN2 HUWE1 IPO4 PLBD2 LMAN1 SCARB2 LRP1 PDCD11 SON AHNAK2 | 9.21e-08 | 1367 | 254 | 30 | 32687490 |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | PAOX YIF1A GSDME RAB43 PKD1 CPNE1 AP1M1 RIC8A OSBP2 DHX29 DIP2B CAMK2G PKP4 CHD9 VARS2 REST IPO4 TERT PPOX SCARB2 TRAPPC10 LIMCH1 HERC4 MUTYH | 9.84e-08 | 925 | 254 | 24 | 28986522 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | HK2 RPS3 RCC1 PRPF6 TTLL12 DIP2B NCAPD3 RANBP2 POLR2A RNF213 NIBAN2 HUWE1 WDHD1 AHNAK2 | 1.88e-07 | 332 | 254 | 14 | 32786267 |
| Pubmed | 3.85e-07 | 3 | 254 | 3 | 38123547 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | EYA4 GBF1 HK2 RPS3 BMS1 RCC1 TTF1 SORT1 NCAPD3 RANBP2 NRF1 POLR2A DYRK1A HUWE1 ELP3 TFCP2 WDHD1 NISCH LRP1 ARHGEF2 CABIN1 SORL1 | 4.12e-07 | 857 | 254 | 22 | 25609649 |
| Pubmed | 5.19e-07 | 41 | 254 | 6 | 21052544 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | GBF1 HK2 RPS3 KIAA0586 PSMB5 BMS1 PSMD2 RCC1 PRPF6 LANCL2 TTLL12 MIF AP1M1 DLST GNB1 DHX29 NCAPD3 RANBP2 POLR1A MTHFD1L POLR2A HUWE1 IPO4 TFCP2 LMAN1 WDR6 SEC11A MTR PDCD11 | 7.19e-07 | 1425 | 254 | 29 | 30948266 |
| Pubmed | ACADL MYO7A RPS3 SEPTIN9 ANKS1B PSMD2 ARID1A LANCL2 SACS SEC16A SYN1 PACS2 DLST GNB1 DHX29 KALRN CAMK2D CAMK2G PKP4 DYRK1A DPYSL4 ELP3 SPTBN4 PACS1 NISCH TRAPPC10 CORO6 LIMCH1 ARHGEF2 | 7.83e-07 | 1431 | 254 | 29 | 37142655 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | RNF130 GBF1 ACADSB SEPTIN9 MGLL TTF1 CEMIP2 SORT1 DOCK5 ZNRF3 MCM3AP SEC16A LRRN2 NUDT19 NCAPD3 MTHFD1L SHC1 RNF213 HUWE1 LMAN1 MACO1 CNDP2 ARHGEF2 SEPTIN10 | 1.14e-06 | 1061 | 254 | 24 | 33845483 |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | GBF1 PTPN13 EML5 RANBP2 POLR1A DYNC2I1 REST HUWE1 LLGL1 CDC25B SON | 1.27e-06 | 232 | 254 | 11 | 25515538 |
| Pubmed | 1.53e-06 | 4 | 254 | 3 | 23283348 | ||
| Pubmed | BMS1 PSMD2 PRPF6 ARID1A TTF1 TTLL12 MCM3AP SEC16A RANBP2 POLR1A MTHFD1L POLR2A HUWE1 IPO4 WDR6 PDCD11 SON PCNT | 1.79e-06 | 653 | 254 | 18 | 22586326 | |
| Pubmed | RPL10L ACADSB RPS3 SEPTIN9 PSMB5 PSMD2 PRPF6 ARID1A LANCL2 SEC16A GNB1 GMPPB CNOT2 RANBP2 CAMK2D POLR2A PKP4 SHC1 CHD9 HUWE1 RUNX1 PPM1B CNDP2 TRAPPC10 LIMCH1 ARHGEF2 | 1.81e-06 | 1247 | 254 | 26 | 27684187 | |
| Pubmed | RPL10L GBF1 ATP7A HK2 RPS3 PSMD2 PRPF6 AP1M1 DLST CNOT2 DIP2B NCAPD3 RANBP2 NIBAN1 MTHFD1L CAMK2D CAMK2G RNF213 HUWE1 IPO4 LMAN1 NISCH SCARB2 CHID1 PCNT | 1.82e-06 | 1168 | 254 | 25 | 19946888 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | HK2 ACADSB PSMB5 BMS1 PSMD2 SEC16A DLST MTO1 GNB1 NUDT19 DIP2B MTHFD1L SHC1 DYNC2I1 RNF213 VARS2 HUWE1 TFCP2 LMAN1 WDR6 MACO1 NISCH MTR PDCD11 PRKCQ ARHGEF2 SON AHNAK2 PCNT | 1.89e-06 | 1496 | 254 | 29 | 32877691 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | PSMB5 ADGRV1 CEMIP2 PTPN13 EML5 FAM151A RAB43 MIF PKD1 AP1M1 GNB1 ALDH9A1 ALPL AMN NRF1 KALRN NIBAN2 HUWE1 CR1 SCARB2 CNDP2 PCK1 SORL1 | 1.91e-06 | 1016 | 254 | 23 | 19056867 |
| Pubmed | Interaction network of human early embryonic transcription factors. | EYA4 KLF3 ARID1A SORT1 KMT2C MCM3AP SEC16A RANBP2 ZHX2 CRX WDR6 NCOA1 ZFHX3 | 2.20e-06 | 351 | 254 | 13 | 38297188 |
| Pubmed | ZFYVE16 CEMIP2 SEC16A ALDH9A1 CNOT2 ANKS1A POLR1A POLR2A DYNC2I1 RNF213 HUWE1 LYSMD3 WDHD1 WDR6 N4BP2 MACO1 MTR CEP295 ARHGEF2 | 2.26e-06 | 733 | 254 | 19 | 34672954 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | EYA4 GBF1 RPS3 NPHP4 CEMIP2 SEC16A DNAH8 POLR2A SHC1 HEXD PPM1A PPM1B LRP1 CDC25B | 3.04e-06 | 420 | 254 | 14 | 28065597 |
| Pubmed | 3.07e-06 | 55 | 254 | 6 | 33067418 | ||
| Pubmed | Regulation of MAGE-A3/6 by the CRL4-DCAF12 ubiquitin ligase and nutrient availability. | 4.22e-06 | 89 | 254 | 7 | 31267705 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | LAMA1 PSMB5 PRPF6 SFXN2 DGCR8 CNOT2 CACNB1 RANBP2 CAMK2D DYRK1A PELI1 HUWE1 GTF2H2 WDR6 MTR PDCD11 SON SORL1 | 4.26e-06 | 695 | 254 | 18 | 23602568 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | RPS3 SEPTIN9 PRPF6 GDAP1L1 SACS MIF SEC16A SYN1 RIC8A DHX29 ANKS1A DIP2B CAMK2G POLR2A IPO4 | 4.62e-06 | 498 | 254 | 15 | 36634849 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | CAND2 HK2 PSMD2 SORT1 TTLL12 YIF1A ZNRF3 RIC8A GNB1 ZNHIT2 NCAPD3 RANBP2 POLR1A CAMK2D HUWE1 IPO4 LMAN1 NISCH SEC11A MTR ARHGEF2 | 6.85e-06 | 942 | 254 | 21 | 31073040 |
| Pubmed | Trafficking of TRPP2 by PACS proteins represents a novel mechanism of ion channel regulation. | 7.58e-06 | 6 | 254 | 3 | 15692563 | |
| Pubmed | HK2 PELI3 ARID1A CES2 KCNH2 PLA2G4F MMP16 CAMK2G POLR2A PELI1 PPM1A PPM1B LLGL1 LRP1 CORO6 PRKCQ CDC25B KLHL17 | 8.31e-06 | 730 | 254 | 18 | 34857952 | |
| Pubmed | EYA4 ZFYVE16 RPS3 KIAA0586 WDR54 LANCL2 AP1M1 MTO1 PRMT7 CAMK2D RNF213 HUWE1 PLBD2 LLGL1 WDR6 HERC4 | 1.11e-05 | 604 | 254 | 16 | 38803224 | |
| Pubmed | 1.19e-05 | 104 | 254 | 7 | 9205841 | ||
| Pubmed | DOCK4 HK2 ACADL SEPTIN9 ANKS1B PSMD2 NACAD MIF AP1M1 DLST ALDH9A1 DHX29 CNOT2 CACNB1 RANBP2 KALRN CAMK2D CAMK2G HUWE1 TENM1 CNDP2 SEPTIN10 PCDH8 | 1.22e-05 | 1139 | 254 | 23 | 36417873 | |
| Pubmed | 1.32e-05 | 7 | 254 | 3 | 29093530 | ||
| Pubmed | ZFYVE16 RCC1 PTPN13 SEC16A RANBP2 CAMK2G HUWE1 LMAN1 WDR6 N4BP2 LRP1 ZFHX3 PCNT | 1.43e-05 | 418 | 254 | 13 | 34709266 | |
| Pubmed | ATP7A CEMIP2 PTPN13 DENND4B SEC16A PKP4 NIBAN2 PACS1 LLGL1 TENM3 WDR6 NISCH MTSS2 | 1.55e-05 | 421 | 254 | 13 | 36976175 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RPS3 BMS1 RCC1 PRPF6 LMTK3 ARID1A LHX2 PTPN13 SACS CPNE1 DLST GNB1 DIP2B RANBP2 KALRN POLR2A DPYSL4 CHD9 LLGL1 SEC11A ARHGEF2 SON | 1.72e-05 | 1082 | 254 | 22 | 38697112 |
| Pubmed | ANKS1B SYN1 GNB1 ANKS1A DIP2B KALRN CAMK2D CAMK2G SPTBN4 LRP1 | 1.77e-05 | 251 | 254 | 10 | 27507650 | |
| Pubmed | ANKS1B ADGRV1 PTPN13 ACAN GNB1 MTHFD1L DYNC2I1 RNF222 CPE ELP3 LLGL1 TRAPPC10 MTSS2 | 1.93e-05 | 430 | 254 | 13 | 32581705 | |
| Pubmed | A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition. | RPS3 RCC1 ADGRV1 ZNRF3 MCM3AP GNB1 MTHFD1L HUWE1 IPO4 TERT PPP2R3A MTR PDCD11 | 1.98e-05 | 431 | 254 | 13 | 33660365 |
| Pubmed | GBF1 CEMIP2 YIF1A GSDME SEC16A PRMT7 DHX29 RANBP2 SHC1 NIBAN2 LYSMD3 LMAN1 MACO1 LIMCH1 AHNAK2 | 2.17e-05 | 568 | 254 | 15 | 37774976 | |
| Pubmed | RPL10L ANKS1B ANKRD30B PSMD2 RCC1 PRPF6 ARID1A DDX11 SACS DLST GNB1 DNAH8 PREX1 RANBP2 CAMK2G SPTBN4 SUGCT N4BP2 TENM1 CEP295 LIMCH1 G6PC2 ARHGEF2 SEPTIN10 PCK1 PCNT | 2.32e-05 | 1442 | 254 | 26 | 35575683 | |
| Pubmed | 2.64e-05 | 210 | 254 | 9 | 16565220 | ||
| Pubmed | ZFYVE16 SEPTIN9 ARID1A PTPN13 SEC16A ANKS1A RANBP2 MACO1 TENM1 AHNAK2 | 2.64e-05 | 263 | 254 | 10 | 34702444 | |
| Pubmed | 2.70e-05 | 118 | 254 | 7 | 30979931 | ||
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | 2.73e-05 | 264 | 254 | 10 | 32814769 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | DOCK4 GBF1 PSMB5 PSMD2 PRPF6 SORT1 KMT2C MIF PREX1 ANKS1A RANBP2 MTHFD1L CAMK2D POLR2A DYRK1A CASP4 IPO4 PPM1A PPM1B SEC11A MTR ARHGEF2 CDC25B SON | 2.75e-05 | 1284 | 254 | 24 | 17353931 |
| Pubmed | GBF1 CEMIP2 GSDME DLST GMPPB NIBAN1 CAMK2D DPYSL4 NIBAN2 HUWE1 NISCH | 3.06e-05 | 325 | 254 | 11 | 36168628 | |
| Pubmed | 3.29e-05 | 216 | 254 | 9 | 31519766 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYO7A SEPTIN9 LAMA1 BMS1 OBSCN TTLL12 DOCK5 KMT2C DENND4B MCM3AP PKD1 PLXNB3 POLR2A RNF213 HUWE1 PPM1A CEP295 | 3.38e-05 | 736 | 254 | 17 | 29676528 |
| Pubmed | A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export. | HK2 SEPTIN9 PSMD2 ARID1A AP1M1 RANBP2 POLR1A MTHFD1L POLR2A HUWE1 WDR6 SCARB2 | 3.57e-05 | 392 | 254 | 12 | 33144569 |
| Pubmed | 4.17e-05 | 172 | 254 | 8 | 27375898 | ||
| Pubmed | 4.41e-05 | 87 | 254 | 6 | 20801516 | ||
| Pubmed | 5.31e-05 | 2 | 254 | 2 | 26242627 | ||
| Pubmed | 5.31e-05 | 2 | 254 | 2 | 27964993 | ||
| Pubmed | 5.31e-05 | 2 | 254 | 2 | 31201299 | ||
| Pubmed | Xenobiotic Response Elements (XREs) from Human CYP1A1 Gene Enhance the hTERT Promoter Activity. | 5.31e-05 | 2 | 254 | 2 | 31201638 | |
| Pubmed | Coding variants in the PCNT and CEP295 genes contribute to breast cancer risk in Chinese women. | 5.31e-05 | 2 | 254 | 2 | 34418690 | |
| Pubmed | Ligation of erythrocyte CR1 induces its clustering in complex with scaffolding protein FAP-1. | 5.31e-05 | 2 | 254 | 2 | 18684861 | |
| Pubmed | REST regulates DYRK1A transcription in a negative feedback loop. | 5.31e-05 | 2 | 254 | 2 | 21252229 | |
| Pubmed | 5.31e-05 | 2 | 254 | 2 | 33247227 | ||
| Pubmed | 5.31e-05 | 2 | 254 | 2 | 31619570 | ||
| Pubmed | 5.31e-05 | 2 | 254 | 2 | 3118371 | ||
| Pubmed | 5.31e-05 | 2 | 254 | 2 | 26567004 | ||
| Pubmed | 5.31e-05 | 2 | 254 | 2 | 22496420 | ||
| Pubmed | Dephosphorylation of cyclin-dependent kinases by type 2C protein phosphatases. | 5.31e-05 | 2 | 254 | 2 | 10580002 | |
| Pubmed | 5.31e-05 | 2 | 254 | 2 | 25124496 | ||
| Pubmed | 5.31e-05 | 2 | 254 | 2 | 28476937 | ||
| Pubmed | SON DNA-binding protein mediates macrophage autophagy and responses to intracellular infection. | 5.31e-05 | 2 | 254 | 2 | 32484234 | |
| Pubmed | 5.31e-05 | 2 | 254 | 2 | 38597448 | ||
| Pubmed | 5.31e-05 | 2 | 254 | 2 | 21252065 | ||
| Pubmed | 5.31e-05 | 2 | 254 | 2 | 30926958 | ||
| Pubmed | 5.31e-05 | 2 | 254 | 2 | 1492743 | ||
| Pubmed | A shortcut to the lysosome: the mannose-6-phosphate-independent pathway. | 5.31e-05 | 2 | 254 | 2 | 22884962 | |
| Pubmed | Metalloproteinase PAPP-A regulation of IGF-1 contributes to polycystic kidney disease pathogenesis. | 5.31e-05 | 2 | 254 | 2 | 31990681 | |
| Pubmed | 5.31e-05 | 2 | 254 | 2 | 19939248 | ||
| Pubmed | 5.31e-05 | 2 | 254 | 2 | 25193973 | ||
| Pubmed | 5.31e-05 | 2 | 254 | 2 | 14652357 | ||
| Pubmed | 5.31e-05 | 2 | 254 | 2 | 15901843 | ||
| Pubmed | Adipocyte CAMK2 deficiency improves obesity-associated glucose intolerance. | 5.31e-05 | 2 | 254 | 2 | 34303021 | |
| Pubmed | Loss of RE-1 silencing transcription factor accelerates exocrine damage from pancreatic injury. | 5.31e-05 | 2 | 254 | 2 | 32080178 | |
| Pubmed | 5.31e-05 | 2 | 254 | 2 | 26953344 | ||
| Pubmed | 5.31e-05 | 2 | 254 | 2 | 35716086 | ||
| Pubmed | 5.31e-05 | 2 | 254 | 2 | 29992531 | ||
| Pubmed | 5.31e-05 | 2 | 254 | 2 | 18771760 | ||
| Pubmed | Regulation of human MutYH DNA glycosylase by the E3 ubiquitin ligase mule. | 5.31e-05 | 2 | 254 | 2 | 24443563 | |
| Pubmed | Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease. | 5.31e-05 | 2 | 254 | 2 | 25961459 | |
| Pubmed | 5.31e-05 | 2 | 254 | 2 | 36525890 | ||
| Interaction | DNAJC7 interactions | LAMA1 PSMD2 NPHP4 EML5 SACS SEC16A DLST MTO1 ALDH9A1 NPAS1 NUDT19 DYRK1A HUWE1 IPO4 LLGL1 LMAN1 WDR6 MTR CNDP2 HERC4 PCNT | 8.15e-08 | 425 | 249 | 21 | int:DNAJC7 |
| Interaction | TOP3B interactions | GBF1 MYO7A OBSCN RAP1GAP2 RCC1 ARID1A NPHP4 TBC1D9 KMT2C ZNRF3 KCNH2 RAB43 MCM3AP PKD1 SEC16A DLST RIC8A METTL27 PREX1 CNOT2 NUDT19 SEMA6C FRAS1 NRF1 KALRN MTHFD1L POLR2A SHC1 DYRK1A HUWE1 IPO4 TFCP2 NISCH PDCD11 ARHGEF2 ZNF839 CABIN1 AHNAK2 PCNT KLHL17 | 1.92e-06 | 1470 | 249 | 40 | int:TOP3B |
| Interaction | EPHA5 interactions | ZFYVE16 PTPN13 GNB1 NUDT19 PKP4 SHC1 NIBAN2 WDR6 NISCH SEPTIN10 | 1.25e-05 | 144 | 249 | 10 | int:EPHA5 |
| Interaction | RMC1 interactions | HK2 SEPTIN9 PSMD2 ARID1A RANBP2 POLR1A MTHFD1L POLR2A HUWE1 WDR6 | 2.00e-05 | 152 | 249 | 10 | int:RMC1 |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.70e-04 | 57 | 165 | 5 | 1179 | |
| GeneFamily | Pellino E3 ubiquitin protein ligases | 2.47e-04 | 3 | 165 | 2 | 676 | |
| GeneFamily | WD repeat domain containing | 6.90e-04 | 262 | 165 | 9 | 362 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK4 GBF1 ZFYVE16 AVL9 SEPTIN9 MGLL PTPN13 SACS CNOT2 ANKS1A RANBP2 PKP4 DYRK1A CHD9 RUNX1 ZHX2 PPM1B PPP2R3A WDHD1 MTR NCOA1 ZFHX3 HERC4 SON PCNT | 9.18e-07 | 856 | 252 | 25 | M4500 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | GBF1 SEPTIN9 KLF3 PSMD2 CEMIP2 KMT2C DHX29 FRAS1 PKP4 DYNC2I1 CHD9 REST MACO1 LRP1 ZFHX3 ARHGEF2 SEPTIN10 | 3.21e-06 | 467 | 252 | 17 | M1347 |
| Coexpression | GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN | MBTPS1 AVL9 KLF3 MGLL KMT2C LIPG RIC8A CNOT2 DYRK1A HUWE1 LYSMD3 | 4.10e-06 | 200 | 252 | 11 | M9486 |
| Coexpression | GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_DN | SPIB PRPF6 EML5 PKD1 METTL27 PREX1 POLR2A CXXC5 ZBTB12 NISCH NCOA1 | 4.10e-06 | 200 | 252 | 11 | M4667 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | GBF1 SEPTIN9 KLF3 PSMD2 CEMIP2 KMT2C DHX29 FRAS1 PKP4 DYNC2I1 CHD9 REST MACO1 LRP1 ZFHX3 ARHGEF2 SEPTIN10 | 5.15e-06 | 484 | 252 | 17 | MM999 |
| Coexpression | GSE32255_UNSTIM_VS_4H_LPS_STIM_DC_UP | 1.37e-05 | 186 | 252 | 10 | M8914 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN | 1.69e-05 | 84 | 252 | 7 | M13008 | |
| Coexpression | GSE3982_NKCELL_VS_TH1_UP | SPTLC3 FBXO40 CAND2 ADGRV1 LIPG NPAS1 PPP2R3A NCOA1 G6PC2 MUTYH | 2.07e-05 | 195 | 252 | 10 | M5593 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | SEPTIN9 RAP1GAP2 ANKRD30B ANKMY1 WDR54 LMTK3 CES2 MCM3AP CPNE1 AP1M1 CENATAC ANKS1A NIBAN2 HEXD PPOX WDR6 NISCH CNDP2 ZFHX3 ZNF839 MUTYH MX1 PCNT | 2.40e-05 | 905 | 252 | 23 | M40865 |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_1H_BMDC_UP | MYO7A AP1M1 DLST GMPPB ZNHIT2 DNAH8 NUDT19 SLC9A8 LRP1 CHID1 | 2.57e-05 | 200 | 252 | 10 | M3852 |
| Coexpression | GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN | SEPTIN9 MGLL DOCK5 DENND4B ALDH9A1 NATD1 IPO4 SCARB2 LRP1 TRAPPC10 | 2.57e-05 | 200 | 252 | 10 | M6626 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | MAGEA3 EYA4 SAMD9 HK2 OBSCN RCC1 ST7L NPHP4 DDX11 DOCK5 ACAN MIF PRMT7 CAMK2G ASAP3 CASP4 DPYSL4 RUNX1 TERT LRP1 LIMCH1 STAG3 | 7.44e-05 | 909 | 252 | 22 | M41018 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | DOCK4 ATP7A KIAA0586 ARID1A MAP3K1 CEMIP2 GSDME SOHLH2 SFXN2 MMP16 PKP4 RNF213 PELI1 CHD9 REST HUWE1 RUNX1 LYSMD3 PPM1A MACO1 NISCH ZFHX3 CEP295 G6PC2 CCNB1IP1 STAG3 CPEB1 | 9.02e-07 | 804 | 248 | 27 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | DOCK4 ATP7A KIAA0586 ARID1A MAP3K1 CEMIP2 GSDME SOHLH2 SFXN2 MMP16 SEMA6C POLR1A PKP4 RNF213 PELI1 CHD9 REST LYSMD3 MACO1 NISCH MTR CEP295 CCNB1IP1 STAG3 CPEB1 | 9.33e-06 | 806 | 248 | 25 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | DOCK4 ATP7A KIAA0586 ARID1A CEMIP2 GSDME SFXN2 MMP16 NRF1 PKP4 DPYSL4 PELI1 CHD9 REST ELP3 LYSMD3 TFAP2B PPM1A MACO1 NISCH ZFHX3 CEP295 G6PC2 PCDH8 | 3.28e-05 | 815 | 248 | 24 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | MAP3K1 SFXN2 MMP16 SEMA6C NCAPD3 PKP4 PELI1 CHD9 LYSMD3 NISCH LRP1 CEP295 | 3.90e-05 | 249 | 248 | 12 | gudmap_developingGonad_P2_epididymis_1000_k3 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | SPTLC3 ABCA13 LAMA1 ZNRF3 LRRN2 FRAS1 PKP4 CPE ZHX2 PPP2R3A TENM1 PRKCQ RP1 | 6.41e-11 | 186 | 255 | 13 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | SPTLC3 ABCA13 LAMA1 ADGRV1 ZNRF3 LRRN2 PKP4 ZHX2 PPP2R3A TENM1 PRKCQ RP1 | 9.99e-10 | 188 | 255 | 12 | af740fa78542438fdff627ea1f74f4eee43316be |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | EML5 FAM151A SEC16A SCNN1B PKP4 CPE SPTBN4 TENM3 NISCH NCOA1 G6PC2 SON | 9.99e-10 | 188 | 255 | 12 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | SPTLC3 ABCA13 LAMA1 ZNRF3 LRRN2 PKP4 ZHX2 PPP2R3A TENM1 PRKCQ RP1 | 1.18e-08 | 187 | 255 | 11 | c31130fc2f9f882944b2ba366a034a03f051c4b9 |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RAP1GAP2 EML5 FAM151A SEC16A SCG5 CPE HUWE1 WDR6 NISCH G6PC2 SON | 1.72e-08 | 194 | 255 | 11 | 0b023de48ed8a550d169bbe954881eb04bf4f981 |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | EYA4 ACADL SEPTIN9 ANKS1B TBC1D9 SORT1 PTPN13 TENM3 MTR PAPPA | 1.64e-07 | 191 | 255 | 10 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | ZFYVE16 AVL9 ADGRV1 ARID1A DIP2B RANBP2 HUWE1 N4BP2 TRAPPC10 SON | 1.80e-07 | 193 | 255 | 10 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-07 | 193 | 255 | 10 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-07 | 194 | 255 | 10 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CPAMD8 EYA4 ACADL ANKS1B TBC1D9 SORT1 PTPN13 TENM3 MTR PAPPA | 1.89e-07 | 194 | 255 | 10 | 69bff17df4a760ccf081cf52ff04af02c14f448d |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | ZFYVE16 ANKS1B NACAD SORT1 DOCK5 PTPN13 PACS2 PEX5L PPP2R3A LIMCH1 | 1.89e-07 | 194 | 255 | 10 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-07 | 195 | 255 | 10 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-07 | 167 | 255 | 9 | b94e8ee8c3fcebedd8fcd719eadddc04c7513c50 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.25e-07 | 170 | 255 | 9 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-06 | 183 | 255 | 9 | b5ede5a0048c585b73c00e88aeddbcaf669347b1 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.38e-06 | 187 | 255 | 9 | 6f7f293c9cf35261e0e3614e46ec1fb00a701b63 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-06 | 187 | 255 | 9 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 1.65e-06 | 191 | 255 | 9 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 1.79e-06 | 193 | 255 | 9 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-06 | 193 | 255 | 9 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-06 | 194 | 255 | 9 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-06 | 195 | 255 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.95e-06 | 195 | 255 | 9 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-06 | 196 | 255 | 9 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.22e-06 | 198 | 255 | 9 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | COVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.31e-06 | 199 | 255 | 9 | 155b03b859157013e9142e9248551369127d9204 | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.05e-06 | 154 | 255 | 8 | 43735f7c58cac51855ded486ee8d8729a1b9909e | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.05e-06 | 154 | 255 | 8 | d55fb73461885e1e02061a344ff89624ef4de487 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.44e-06 | 162 | 255 | 8 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-06 | 168 | 255 | 8 | dd48da83c32d41a62f80cd7e5e5c64e42776fa27 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.07e-06 | 169 | 255 | 8 | 58e22f9119240664515fe91ca53812611a8f17d6 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Slc17a7-Slc17a6.Calb1-Rorb-Il1rapl2_(Layer_5b)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.61e-06 | 80 | 255 | 6 | 402aba070f0728ebda9db7a8fa85441533755ff4 | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-CD79a_B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.90e-06 | 172 | 255 | 8 | 0c6332a806ac75fffae6080f61965555c7f687f4 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.20e-06 | 173 | 255 | 8 | e05cddf5bf63cf419343ff229453327519765be8 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.20e-06 | 173 | 255 | 8 | 74ad5ed33821b8816c9c8e67c50ee4496ba18e2f | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-06 | 174 | 255 | 8 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.84e-06 | 175 | 255 | 8 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.17e-06 | 176 | 255 | 8 | c6484334187f64cd00cd35e77d8ae436556b4260 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.17e-06 | 176 | 255 | 8 | 8eb91dcf55d4e3e28a72d447181bf6d2ad891fc6 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.17e-06 | 176 | 255 | 8 | e74ad0db3b05897edcfabeb11008ede2b9eeb638 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.52e-06 | 177 | 255 | 8 | b01d7a6a78169962123ddfb0bb588f51d138ad02 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.52e-06 | 177 | 255 | 8 | 426a9845df7fd13b02e744532c336c60bc4d4a22 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.52e-06 | 177 | 255 | 8 | 1dc69c661e70e7e22bd9d7cf953eb638da9fd43c | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.52e-06 | 177 | 255 | 8 | 71919b5c9bfa87fdd2cd44dfa057b66ea081be5d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-05 | 181 | 255 | 8 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-05 | 181 | 255 | 8 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-05 | 182 | 255 | 8 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.09e-05 | 183 | 255 | 8 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 184 | 255 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 184 | 255 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.13e-05 | 184 | 255 | 8 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 184 | 255 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 185 | 255 | 8 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | Myeloid-B_(Activated_Macrophage)|World / shred on cell class and cell subclass (v4) | 1.22e-05 | 186 | 255 | 8 | 33d731a7883d75e4e7db83b641cdb1e9a39938bf | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-05 | 186 | 255 | 8 | 7950e03ea080238c168b9d807e217f459acdfb28 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-05 | 187 | 255 | 8 | dfc2b95d70daf533bc0cc4ce78af9f65dd75a25b | |
| ToppCell | droplet-Pancreas|droplet / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 187 | 255 | 8 | 5f4df092452d8672bda4059c794e099ba3f5a8fa | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-05 | 188 | 255 | 8 | 58ccb31cdf43167872ef0fc737e6f9c51ee2e060 | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.32e-05 | 188 | 255 | 8 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 1.32e-05 | 188 | 255 | 8 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 189 | 255 | 8 | fc88c51ace7d883c01617f3f9b5fab70cc91cc09 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 190 | 255 | 8 | 1cf023e3c6924d6a06f353d4b62444b6f2fee8a7 | |
| ToppCell | MatrixFB-Fibroblast-C|MatrixFB / shred on cell class and cell subclass (v4) | 1.43e-05 | 190 | 255 | 8 | d0106f7a21292f0b96ce4337ec3efbb1bd78dd0a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 190 | 255 | 8 | bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 190 | 255 | 8 | b6b8964b4910083499681b5fdf554e127b6a4c4e | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 191 | 255 | 8 | fd01a206763dfb6d52cca67123571936b4a8e1a0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 191 | 255 | 8 | 2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.48e-05 | 191 | 255 | 8 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.48e-05 | 191 | 255 | 8 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | facs-Pancreas|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 191 | 255 | 8 | d48e5f67d384226add7d7fb2a124954136e09a82 | |
| ToppCell | COVID-19-kidney-TAL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.48e-05 | 191 | 255 | 8 | fe55475ce0666ab5122447a813dc2369e24947b8 | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 192 | 255 | 8 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.54e-05 | 192 | 255 | 8 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 1.54e-05 | 192 | 255 | 8 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | droplet-Pancreas-Endocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 192 | 255 | 8 | 4510aa262da8dcf7c944b3907a51aba5a9397a4e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.54e-05 | 192 | 255 | 8 | 8dc3016601148243196e925641c9507e9d58c9e0 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 192 | 255 | 8 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 1.54e-05 | 192 | 255 | 8 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.66e-05 | 194 | 255 | 8 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 1.66e-05 | 194 | 255 | 8 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 194 | 255 | 8 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-05 | 195 | 255 | 8 | 938b31dbf1674ee6fd0123bc88391ddcaf151217 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Mesofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.72e-05 | 195 | 255 | 8 | a52685f76eca269a7d2de8dfc317439483e233fa | |
| ToppCell | CF-Myeloid|CF / Disease state, Lineage and Cell class | 1.72e-05 | 195 | 255 | 8 | ecf604de496f389a49429d0bb211e1db6019cc8b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-05 | 195 | 255 | 8 | d39e9e6544f49e677ebe528c6fe60b99a3630e30 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Mesofibroblastic-Mesothelia|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.72e-05 | 195 | 255 | 8 | 224deeba2f60def6543a55bb4f5ee6c7fdab3f02 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-05 | 195 | 255 | 8 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.78e-05 | 196 | 255 | 8 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-05 | 196 | 255 | 8 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.78e-05 | 196 | 255 | 8 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.92e-05 | 198 | 255 | 8 | bdabdb11217ea16e5863aa6bfb0f04d48b17f81e | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-05 | 198 | 255 | 8 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-05 | 198 | 255 | 8 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.99e-05 | 199 | 255 | 8 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-B-B_memory|ICU-NoSEP / Disease, condition lineage and cell class | 1.99e-05 | 199 | 255 | 8 | acd2b87ab0d7d92515cf46ab65b766d6ade818a6 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Mesothelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.99e-05 | 199 | 255 | 8 | ca970114b5aef4518ce580897a62ac88688b2671 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.99e-05 | 199 | 255 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Control-Control-Myeloid-Neutrophil|Control / Disease, condition lineage and cell class | 2.06e-05 | 200 | 255 | 8 | 95c41f147a1594d49e73cb56d86d301c3115ce20 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.06e-05 | 200 | 255 | 8 | 65c83a3f6ee2a10bcb5b95076696232c6373a7b4 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.06e-05 | 200 | 255 | 8 | 40e969883bc302e8fbc6b6ab9814529dc1472902 | |
| Drug | Cefotetan [69712-56-7]; Up 200; 7uM; MCF7; HT_HG-U133A | LHX2 DGCR8 TBX5 CACNB1 CASP4 HUWE1 RUNX1 TFAP2B LLGL1 TENM1 PAPPA ARHGEF2 PCK1 AHNAK2 | 3.71e-08 | 197 | 248 | 14 | 4116_UP |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | SPTLC3 SAMD9 ARID1A SORT1 PAOX KCNH2 CAMK2G CASP4 RUNX1 TENM3 ZNF701 PCK1 MTSS2 | 3.05e-07 | 199 | 248 | 13 | 4843_DN |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Up 200; 10.4uM; HL60; HT_HG-U133A | AVL9 CHRNA4 PAOX GSDME DGCR8 ASAP3 RUNX1 CR1 LLGL1 G6PC2 PCK1 MTSS2 | 1.65e-06 | 195 | 248 | 12 | 2386_UP |
| Drug | PHA-00767505E [723337-45-9]; Down 200; 10uM; PC3; HT_HG-U133A | SPTLC3 EYA4 SAMD9 ACADL AVL9 KLF3 RCC1 DGCR8 SLC9A8 GPR17 RUNX1 MX1 | 1.74e-06 | 196 | 248 | 12 | 6591_DN |
| Drug | (-)-MK 801 hydrogen maleate [77086-19-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | SEPTIN9 KLF3 ARID1A PAOX ACAN MCM3AP OSBP2 SLC9A8 NRF1 PPP2R3A LMAN1 CABIN1 | 1.93e-06 | 198 | 248 | 12 | 6657_DN |
| Drug | Piroxicam [36322-90-4]; Down 200; 12uM; HL60; HG-U133A | PAOX ACAN MCM3AP DGCR8 ZNHIT2 PKP4 TERT LMAN1 NCOA1 ARHGEF2 CABIN1 | 9.79e-06 | 194 | 248 | 11 | 1405_DN |
| Drug | clofibrate; Up 200; 150uM; MCF7; HG-U133A | SEPTIN9 ANKMY1 ARID1A MCM3AP FRAS1 KALRN DYRK1A HUWE1 RUNX1 PACS1 MX1 | 9.79e-06 | 194 | 248 | 11 | 263_UP |
| Drug | Naftifine hydrochloride [65473-14-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A | CYP1A1 RCC1 ANKMY1 PAOX LHX2 KCNH2 CAMK2G ASAP3 DPYSL4 WDHD1 ZNF701 | 1.08e-05 | 196 | 248 | 11 | 3536_DN |
| Drug | Phensuximide [86-34-0]; Up 200; 21.2uM; PC3; HT_HG-U133A | MYO7A LIPG MMP16 CACNB1 GPR17 ASAP3 DYRK1A XDH RUNX1 ZFHX3 CABIN1 | 1.08e-05 | 196 | 248 | 11 | 5097_UP |
| Drug | Gramine [87-52-5]; Up 200; 23uM; PC3; HT_HG-U133A | RPL10L CYP1A1 FBXO40 ACAN RUNX1 PEX5L PACS1 TENM1 G6PC2 HERC4 PCK1 | 1.08e-05 | 196 | 248 | 11 | 3999_UP |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HG-U133A | BMS1 PRPF6 NPHP4 SACS ZNHIT2 SLC9A8 CHD9 RUNX1 ELP3 LLGL1 ARHGEF2 | 1.13e-05 | 197 | 248 | 11 | 490_DN |
| Drug | Dinoprost trometamol [38362-01-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A | ARID1A GSDME KCNH2 ACAN SLC25A21 SLC9A8 CAMK2G CPE LLGL1 TENM1 HERC4 | 1.19e-05 | 198 | 248 | 11 | 5409_UP |
| Drug | Levamisole hydrochloride [16595-80-5]; Up 200; 16.6uM; PC3; HT_HG-U133A | MYO7A KLF3 ANKMY1 MMP16 SLC25A21 XDH REST RUNX1 PEX5L LRP1 ZFHX3 | 1.19e-05 | 198 | 248 | 11 | 2094_UP |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; PC3; HT_HG-U133A | CYP1A1 EYA4 SPIB RPS3 KCNH2 OSBP2 DGCR8 SLC9A8 PKP4 RUNX1 TENM1 | 1.19e-05 | 198 | 248 | 11 | 4446_UP |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A | RPL10L ANKMY1 ARID1A KCNH2 DGCR8 SLC9A8 CAMK2G RUNX1 PPM1A PACS1 PPP2R3A | 1.19e-05 | 198 | 248 | 11 | 3405_UP |
| Drug | Tolfenamic acid [13710-19-5]; Up 200; 15.2uM; PC3; HT_HG-U133A | RPL10L FBXO40 SPIB DOCK5 MCM3AP DGCR8 NRF1 REST HUWE1 SCARB2 CPEB1 | 1.19e-05 | 198 | 248 | 11 | 6354_UP |
| Drug | Ceforanide [60925-61-3]; Up 200; 7.6uM; PC3; HT_HG-U133A | RPL10L RCC1 PAOX SCNN1B SLC25A21 PKP4 RUNX1 TENM1 PAPPA G6PC2 MX1 | 1.19e-05 | 198 | 248 | 11 | 6751_UP |
| Drug | Palmatine chloride [3486-67-7]; Up 200; 10.4uM; PC3; HT_HG-U133A | RCC1 SORT1 KCNH2 NPAS1 SLC9A8 AMN ASAP3 CASP4 RUNX1 HERC4 STAG3 | 1.24e-05 | 199 | 248 | 11 | 6612_UP |
| Drug | PF-00539758-00 [351321-34-1]; Down 200; 10uM; PC3; HT_HG-U133A | 1.24e-05 | 199 | 248 | 11 | 6379_DN | |
| Drug | Levodopa [59-92-7]; Up 200; 20.2uM; PC3; HT_HG-U133A | RPL10L SEPTIN9 ANKMY1 ST7L PAOX ACAN RUNX1 TENM1 LRP1 PCK1 MTSS2 | 1.24e-05 | 199 | 248 | 11 | 4571_UP |
| Drug | fullerene C60 | EYA4 MYO7A NPHP4 SLC39A8 MAP3K1 CEMIP2 DDX11 FAM151A SYN1 AP1M1 OSBP2 PRMT7 PREX1 ANKS1A SLC9A8 AMN KALRN POLR2A PRPH2 XDH NIBAN2 REST ZHX2 PACS1 GTF2H2 LLGL1 WDR6 SUSD5 NISCH LPO LRP1 TRAPPC10 PAPPA CDC25B CPEB1 | 1.63e-05 | 1498 | 248 | 35 | ctd:C069837 |
| Drug | Tetrandrine [518-34-3]; Up 200; 6.4uM; PC3; HT_HG-U133A | 4.49e-05 | 189 | 248 | 10 | 5821_UP | |
| Drug | aminochrome | 4.68e-05 | 19 | 248 | 4 | CID000170262 | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; PC3; HT_HG-U133A | 5.13e-05 | 192 | 248 | 10 | 4268_UP | |
| Drug | Gramine [87-52-5]; Up 200; 23uM; MCF7; HT_HG-U133A | CYP1A1 FBXO40 SAMD9 TBX5 DYRK1A CASP4 HUWE1 TFAP2B LLGL1 MTSS2 | 5.36e-05 | 193 | 248 | 10 | 4118_UP |
| Drug | PHA-00851261E [724719-49-7]; Up 200; 1uM; MCF7; HT_HG-U133A | KCNH2 MCM3AP DGCR8 MMP16 DYRK1A PRPH2 REST LMAN1 HERC4 PCDH8 | 5.36e-05 | 193 | 248 | 10 | 3857_UP |
| Drug | Dichlororibofuranosylbenzimidazole | 5.51e-05 | 38 | 248 | 5 | ctd:D004004 | |
| Drug | Cholecalciferol [67-97-0]; Down 200; 10.4uM; PC3; HT_HG-U133A | KLF3 ARID1A MMP16 CACNB1 SLC9A8 NRF1 RUNX1 TENM3 ZFHX3 MTSS2 | 5.60e-05 | 194 | 248 | 10 | 6656_DN |
| Drug | Flunisolide [3385-03-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 5.85e-05 | 195 | 248 | 10 | 3828_UP | |
| Drug | Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; PC3; HT_HG-U133A | SAMD9 ACADSB ZFYVE16 SEPTIN9 SCG5 ELP3 PPP2R3A LMAN1 LIMCH1 HERC4 | 5.85e-05 | 195 | 248 | 10 | 4660_DN |
| Drug | Aceclofenac [89796-99-6]; Up 200; 11.2uM; PC3; HT_HG-U133A | EYA4 ACADSB AVL9 RCC1 SLC39A8 CEMIP2 DOCK5 MMP16 RUNX1 CPEB1 | 6.10e-05 | 196 | 248 | 10 | 7269_UP |
| Drug | Mefenamic acid [61-68-7]; Down 200; 16.6uM; PC3; HT_HG-U133A | 6.10e-05 | 196 | 248 | 10 | 1821_DN | |
| Drug | Propidium iodide [25535-16-4]; Up 200; 6uM; MCF7; HT_HG-U133A | SPTLC3 SAMD9 DOCK5 KCNH2 CACNB1 REST TFAP2B ZFHX3 ZNF701 STAG3 | 6.37e-05 | 197 | 248 | 10 | 6277_UP |
| Drug | Ursolic acid [77-52-1]; Down 200; 8.8uM; PC3; HT_HG-U133A | MBTPS1 ZFYVE16 NRF1 CAMK2G TFCP2 LMAN1 SCARB2 TRAPPC10 ZNF701 ZNF839 | 6.37e-05 | 197 | 248 | 10 | 2067_DN |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A | RPL10L KLF3 ANKMY1 MAP3K1 SORT1 PAOX DGCR8 RUNX1 LIMCH1 CABIN1 | 6.37e-05 | 197 | 248 | 10 | 5459_DN |
| Drug | PNU-0293363 [326823-19-2]; Up 200; 10uM; PC3; HT_HG-U133A | EYA4 AVL9 RCC1 ARID1A DGCR8 MMP16 PPP2R3A TENM3 SCARB2 CABIN1 | 6.37e-05 | 197 | 248 | 10 | 6563_UP |
| Drug | Chlorphensin carbamate [886-74-8]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 6.37e-05 | 197 | 248 | 10 | 2279_UP | |
| Drug | Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Up 200; 16.4uM; PC3; HT_HG-U133A | RPL10L ST7L ARID1A TBX5 SLC25A21 GPR17 PKP4 ASAP3 LLGL1 LIMCH1 | 6.37e-05 | 197 | 248 | 10 | 4226_UP |
| Drug | Aconitine [302-27-2]; Up 200; 6.2uM; PC3; HT_HG-U133A | SAMD9 SEPTIN9 RCC1 ANKMY1 MCM3AP MMP16 SCG5 RUNX1 SCARB2 STAG3 | 6.37e-05 | 197 | 248 | 10 | 7149_UP |
| Drug | deferoxamine mesylate salt; Down 200; 100uM; PC3; HG-U133A | 6.37e-05 | 197 | 248 | 10 | 460_DN | |
| Drug | Scopolamine hydrochloride [55-16-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A | SPTLC3 SAMD9 CAND2 ARID1A KCNH2 FRAS1 ASAP3 DYRK1A CASP4 CR1 | 6.37e-05 | 197 | 248 | 10 | 3357_UP |
| Drug | Famprofazone [22881-35-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | FBXO40 SAMD9 MCM3AP SCNN1B CACNB1 KALRN CASP4 RUNX1 CR1 MTSS2 | 6.64e-05 | 198 | 248 | 10 | 3928_UP |
| Drug | Alprostadil [745-65-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A | SPTLC3 SAMD9 SPIB MYO7A SEPTIN9 CHRNA4 CACNB1 KALRN REST LLGL1 | 6.64e-05 | 198 | 248 | 10 | 4179_UP |
| Drug | Oxybutynin chloride [1508-65-2]; Up 200; 10.2uM; PC3; HT_HG-U133A | 6.64e-05 | 198 | 248 | 10 | 7126_UP | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 6.64e-05 | 198 | 248 | 10 | 2269_UP | |
| Drug | Pantothenic acid calcium salt monohydrate [63409-48-3]; Up 200; 8uM; MCF7; HT_HG-U133A | CYP1A1 DOCK5 NRF1 CAMK2G XDH LMAN1 MACO1 PAPPA LIMCH1 AHNAK2 | 6.64e-05 | 198 | 248 | 10 | 3248_UP |
| Drug | Naphazoline hydrochloride [550-99-2]; Up 200; 16.2uM; PC3; HT_HG-U133A | RPL10L RCC1 ARID1A MAP3K1 KALRN RUNX1 SUSD5 PRKCQ ARHGEF2 CABIN1 | 6.64e-05 | 198 | 248 | 10 | 6604_UP |
| Drug | Nialamide [51-12-7]; Up 200; 13.4uM; PC3; HT_HG-U133A | 6.64e-05 | 198 | 248 | 10 | 3790_UP | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 10uM; PC3; HT_HG-U133A | 6.93e-05 | 199 | 248 | 10 | 3774_UP | |
| Drug | Petroleum | RPL10L CYP1A1 NLRP12 GBF1 CFB AP1M1 DLST GNB1 ALDH9A1 XDH PPM1A LRP1 | 8.72e-05 | 290 | 248 | 12 | ctd:D010578 |
| Drug | irinotecan | SAMD9 ATP7A HK2 SPIB CES2 PTPN13 DGCR8 SLC25A21 MTHFD1L DYRK1A CASP4 CPE RUNX1 TFCP2 NCOA1 CEP295 CCNB1IP1 CDC25B CABIN1 PCK1 | 9.55e-05 | 703 | 248 | 20 | ctd:C051890 |
| Drug | benzotriazol-1-yl-tris(dimethylamino)phosphonium | 1.18e-04 | 2 | 248 | 2 | CID010938827 | |
| Drug | 1-(1H-indol-3-yl)-9H-pyrido(3,4-b)indole | 1.18e-04 | 2 | 248 | 2 | ctd:C561449 | |
| Drug | o,p'-DDT | MAGEA3 CYP1A1 RPS3 PSMB5 PSMD2 CFB CES2 LIPG KCNH2 NIBAN1 CASP4 PELI1 RUNX1 NCOA1 PCK1 | 1.38e-04 | 451 | 248 | 15 | ctd:C016340 |
| Drug | thioanisole | 1.45e-04 | 25 | 248 | 4 | CID000007520 | |
| Drug | hydroxyl radicals | CYP1A1 NLRP12 ATP7A HK2 ACADL ACADSB CYP21A2 MGLL CFB CES2 DOCK5 PAOX PTPN13 LIPG ALDH9A1 ALPL CA7 MTHFD1L XDH PPM1A PPM1B PPOX PPP2R3A LPO LRP1 MTR PRKCQ G6PC2 CDC25B PCK1 | 1.50e-04 | 1341 | 248 | 30 | CID000000961 |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.52e-04 | 178 | 248 | 9 | 1112_DN | |
| Drug | 3',4',5,7-tetrahydroxyflavanone | 1.56e-04 | 47 | 248 | 5 | CID000011095 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 1.80e-04 | 182 | 248 | 9 | 1891_DN | |
| Drug | Hexetidine [141-94-6]; Up 200; 11.8uM; HL60; HT_HG-U133A | 2.03e-04 | 185 | 248 | 9 | 2457_UP | |
| Drug | Bezafibrate | 2.19e-04 | 229 | 248 | 10 | ctd:D001629 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.20e-04 | 187 | 248 | 9 | 6671_DN | |
| Drug | Rolipram [61413-54-5]; Up 200; 14.6uM; HL60; HT_HG-U133A | 2.39e-04 | 189 | 248 | 9 | 3072_UP | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A | 2.39e-04 | 189 | 248 | 9 | 5084_DN | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 2.58e-04 | 191 | 248 | 9 | 4442_UP | |
| Drug | Denatonium benzoate [3734-33-6]; Down 200; 9uM; HL60; HT_HG-U133A | 2.58e-04 | 191 | 248 | 9 | 3123_DN | |
| Drug | 3-Acetylcoumarin [3949-36-8]; Up 200; 21.2uM; MCF7; HT_HG-U133A | 2.68e-04 | 192 | 248 | 9 | 5624_UP | |
| Drug | Cimetidine [51481-61-9]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 2.68e-04 | 192 | 248 | 9 | 4144_DN | |
| Drug | NSC190421 | 2.76e-04 | 53 | 248 | 5 | CID000002545 | |
| Drug | Tacrine | 2.76e-04 | 53 | 248 | 5 | ctd:D013619 | |
| Drug | Levodopa [59-92-7]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 2.79e-04 | 193 | 248 | 9 | 4394_DN | |
| Drug | Betamethasone [378-44-9]; Down 200; 10.2uM; MCF7; HT_HG-U133A | RNF130 KIAA0586 CEMIP2 ANKS1A CAMK2G POLR2A WDHD1 NCOA1 ZNF839 | 2.89e-04 | 194 | 248 | 9 | 5328_DN |
| Drug | Prednicarbate [73771-04-7]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 2.89e-04 | 194 | 248 | 9 | 5544_DN | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.89e-04 | 194 | 248 | 9 | 4727_DN | |
| Drug | Leflunomide [75706-12-6]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 2.89e-04 | 194 | 248 | 9 | 6102_UP | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.89e-04 | 194 | 248 | 9 | 3855_UP | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; PC3; HT_HG-U133A | 2.89e-04 | 194 | 248 | 9 | 6660_DN | |
| Drug | Finasteride [98319-26-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 2.89e-04 | 194 | 248 | 9 | 3641_UP | |
| Drug | Skimmianine [83-95-4]; Down 200; 15.4uM; HL60; HT_HG-U133A | SEPTIN9 TBC1D9 PRMT7 SLC9A8 CAMK2G ZHX2 LMAN1 TRAPPC10 HERC4 | 2.89e-04 | 194 | 248 | 9 | 2504_DN |
| Drug | trifluoperazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A | 3.01e-04 | 195 | 248 | 9 | 6183_UP | |
| Drug | Naproxen [22204-53-1]; Up 200; 17.4uM; MCF7; HT_HG-U133A | 3.01e-04 | 195 | 248 | 9 | 1706_UP | |
| Drug | Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; PC3; HT_HG-U133A | 3.01e-04 | 195 | 248 | 9 | 5763_DN | |
| Drug | Flumethasone [2135-17-3]; Up 200; 9.8uM; PC3; HT_HG-U133A | 3.01e-04 | 195 | 248 | 9 | 3712_UP | |
| Drug | Sulfamerazine [127-79-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 3.01e-04 | 195 | 248 | 9 | 4740_DN | |
| Drug | Capsaicin [404-86-4]; Up 200; 13uM; HL60; HT_HG-U133A | 3.01e-04 | 195 | 248 | 9 | 3034_UP | |
| Drug | Methazolamide [554-57-4]; Up 200; 17uM; MCF7; HT_HG-U133A | 3.01e-04 | 195 | 248 | 9 | 6268_UP | |
| Drug | Fillalbin [4540-25-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 3.01e-04 | 195 | 248 | 9 | 4172_UP | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 3.01e-04 | 195 | 248 | 9 | 5241_DN | |
| Drug | Cefsulodin sodium salt [52152-93-9]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 3.01e-04 | 195 | 248 | 9 | 4148_UP | |
| Drug | 3 C3 | 3.01e-04 | 30 | 248 | 4 | CID006857689 | |
| Drug | Oxyphenbutazone [129-20-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 3.12e-04 | 196 | 248 | 9 | 6844_DN | |
| Drug | Chlorprothixene hydrochloride [6469-93-8]; Down 200; 11.4uM; PC3; HT_HG-U133A | 3.12e-04 | 196 | 248 | 9 | 6692_DN | |
| Drug | Epicatechin-(-) [154-23-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 3.12e-04 | 196 | 248 | 9 | 4419_UP | |
| Drug | Nitrendipine [39562-70-4]; Up 200; 11uM; MCF7; HT_HG-U133A | 3.12e-04 | 196 | 248 | 9 | 6464_UP | |
| Drug | Phenelzine sulfate [156-51-4]; Down 200; 17uM; PC3; HT_HG-U133A | 3.12e-04 | 196 | 248 | 9 | 4538_DN | |
| Drug | GSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A | 3.12e-04 | 196 | 248 | 9 | 6559_UP | |
| Drug | Sulpiride [15676-16-1]; Down 200; 11.8uM; HL60; HG-U133A | 3.12e-04 | 196 | 248 | 9 | 1967_DN | |
| Drug | Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; PC3; HT_HG-U133A | 3.12e-04 | 196 | 248 | 9 | 4227_DN | |
| Drug | ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A | 3.12e-04 | 196 | 248 | 9 | 7495_DN | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; HL60; HG-U133A | 3.12e-04 | 196 | 248 | 9 | 1445_DN | |
| Disease | Colorectal Carcinoma | CPAMD8 EYA4 ABCA13 LAMA1 OBSCN ARID1A LRRC4 KMT2C GDAP1L1 SACS MCM3AP SCNN1B C12orf76 DNAH8 CACNB1 KALRN MTHFD1L SCG5 ASAP3 CPE PEX5L PPOX TENM1 LRP1 MUTYH SORL1 | 2.63e-10 | 702 | 246 | 26 | C0009402 |
| Disease | peak expiratory flow | CYP1A1 CHRNA4 ACAN PKD1 SFXN2 BRD1 ANKS1A MTHFD1L CAMK2G CXXC5 RUNX1 PACS1 LRP1 NCOA1 SORL1 | 2.15e-05 | 498 | 246 | 15 | EFO_0009718 |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 3.60e-05 | 45 | 246 | 5 | DOID:3748 (is_implicated_in) | |
| Disease | non-small cell lung carcinoma | 3.93e-05 | 75 | 246 | 6 | EFO_0003060 | |
| Disease | atrial fibrillation | EYA4 CAND2 CYP21A2 SLC39A8 KCNH2 TBX5 CAMK2D POLR2A PPP2R3A PAPPA ZFHX3 SORL1 | 7.36e-05 | 371 | 246 | 12 | EFO_0000275 |
| Disease | Autosomal dominant nonsyndromic hearing loss | 9.50e-05 | 29 | 246 | 4 | cv:C5779548 | |
| Disease | acute lymphoblastic leukemia (is_implicated_in) | 9.58e-05 | 55 | 246 | 5 | DOID:9952 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | CYP1A1 OBSCN ARID1A MAP3K1 MIF SCNN1B AP1M1 RIC8A ZNHIT2 KALRN XDH ELP3 TERT CRX LLGL1 N4BP2 NISCH TENM1 MTR NCOA1 PCDH8 SORL1 | 1.06e-04 | 1074 | 246 | 22 | C0006142 |
| Disease | ribulose-phosphate 3-epimerase measurement | 2.07e-04 | 3 | 246 | 2 | EFO_0802025 | |
| Disease | amyotrophic lateral sclerosis, age at onset | 2.42e-04 | 15 | 246 | 3 | EFO_0004847, MONDO_0004976 | |
| Disease | P wave duration | 2.42e-04 | 15 | 246 | 3 | EFO_0005094 | |
| Disease | neutrophil collagenase measurement | 2.96e-04 | 16 | 246 | 3 | EFO_0008248 | |
| Disease | mean arterial pressure | SEPTIN9 ST7L SLC39A8 GSDME ZNRF3 DLST PREX1 NIBAN1 PKP4 RNF213 TERT TFAP2B ZFHX3 | 3.15e-04 | 499 | 246 | 13 | EFO_0006340 |
| Disease | Ciliopathies | 3.28e-04 | 110 | 246 | 6 | C4277690 | |
| Disease | stomach cancer (is_implicated_in) | 3.43e-04 | 72 | 246 | 5 | DOID:10534 (is_implicated_in) | |
| Disease | familial atrial fibrillation | 3.49e-04 | 156 | 246 | 7 | C3468561 | |
| Disease | Persistent atrial fibrillation | 3.49e-04 | 156 | 246 | 7 | C2585653 | |
| Disease | Paroxysmal atrial fibrillation | 3.49e-04 | 156 | 246 | 7 | C0235480 | |
| Disease | Moyamoya Disease | 3.57e-04 | 17 | 246 | 3 | C0026654 | |
| Disease | Atrial Fibrillation | 4.07e-04 | 160 | 246 | 7 | C0004238 | |
| Disease | bitter beverage consumption measurement | 4.11e-04 | 42 | 246 | 4 | EFO_0010089 | |
| Disease | Disorder of eye | 4.29e-04 | 212 | 246 | 8 | C0015397 | |
| Disease | monocyte percentage of leukocytes | NLRP12 KLF3 PSMD2 ARID1A SLC39A8 LHX2 MCM3AP SEC16A AP1M1 SEMA6C POLR1A CHD9 RUNX1 TERT LPO NCOA1 | 4.61e-04 | 731 | 246 | 16 | EFO_0007989 |
| Disease | Acute Myeloid Leukemia, M1 | 6.48e-04 | 125 | 246 | 6 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 6.48e-04 | 125 | 246 | 6 | C1879321 | |
| Disease | X-24020 measurement | 6.81e-04 | 5 | 246 | 2 | EFO_0022128 | |
| Disease | X-13431--nonanoylcarnitine measurement | 6.81e-04 | 5 | 246 | 2 | EFO_0021349 | |
| Disease | Klatskin's tumor (is_implicated_in) | 6.81e-04 | 5 | 246 | 2 | DOID:4927 (is_implicated_in) | |
| Disease | neuroimaging measurement | SAMD9 CYP21A2 KLF3 ST7L SLC39A8 CFB MAP3K1 ZNRF3 DENND4B PKD1 IGSF9 DLST ANKS1A DIP2B CAMK2G CXXC5 DPYSL4 ZHX2 TFCP2 PAPPA | 6.89e-04 | 1069 | 246 | 20 | EFO_0004346 |
| Disease | lung adenocarcinoma (is_implicated_in) | 7.44e-04 | 49 | 246 | 4 | DOID:3910 (is_implicated_in) | |
| Disease | migraine disorder, Headache | 7.78e-04 | 86 | 246 | 5 | HP_0002315, MONDO_0005277 | |
| Disease | obsolete_red blood cell distribution width | CYP1A1 SAMD9 AVL9 CYP21A2 PSMB5 KLF3 ST7L SLC39A8 MAP3K1 DOCK5 ZNRF3 LIPG OSBP2 DIP2B POLR1A NRF1 KALRN NATD1 SCG5 REST RUNX1 HEXD RP1 | 9.59e-04 | 1347 | 246 | 23 | EFO_0005192 |
| Disease | human papilloma virus infection, oropharynx cancer | 1.00e-03 | 53 | 246 | 4 | EFO_0001668, EFO_1001931 | |
| Disease | diastolic blood pressure, social deprivation | 1.02e-03 | 6 | 246 | 2 | EFO_0006336, EFO_0009696 | |
| Disease | nischarin measurement | 1.02e-03 | 6 | 246 | 2 | EFO_0801841 | |
| Disease | Leber congenital amaurosis (is_implicated_in) | 1.02e-03 | 6 | 246 | 2 | DOID:14791 (is_implicated_in) | |
| Disease | urinary metabolite measurement | 1.10e-03 | 245 | 246 | 8 | EFO_0005116 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.13e-03 | 139 | 246 | 6 | DOID:3908 (is_implicated_in) | |
| Disease | myeloproliferative disorder | 1.15e-03 | 25 | 246 | 3 | EFO_0004251 | |
| Disease | Ischemic stroke, fibrinogen measurement | 1.15e-03 | 55 | 246 | 4 | EFO_0004623, HP_0002140 | |
| Disease | Schizophrenia | DOCK4 ABCA13 LAMA1 CHRNA4 EML5 KCNH2 SYN1 DGCR8 BRD1 NPAS1 CASP4 REST LRP1 MTR PCDH8 PCK1 PCNT | 1.27e-03 | 883 | 246 | 17 | C0036341 |
| Disease | blood sedimentation | 1.41e-03 | 7 | 246 | 2 | EFO_0004304 | |
| Disease | acisoga measurement | 1.41e-03 | 7 | 246 | 2 | EFO_0800068 | |
| Disease | X-23641 measurement | 1.41e-03 | 7 | 246 | 2 | EFO_0800854 | |
| Disease | osteocalcin measurement | 1.41e-03 | 7 | 246 | 2 | EFO_0010232 | |
| Disease | congestive heart failure (is_implicated_in) | 1.44e-03 | 27 | 246 | 3 | DOID:6000 (is_implicated_in) | |
| Disease | metabolic syndrome | 1.51e-03 | 200 | 246 | 7 | EFO_0000195 | |
| Disease | basophil measurement | 1.59e-03 | 60 | 246 | 4 | EFO_0803539 | |
| Disease | vital capacity | CYP1A1 EYA4 PCDHA9 CAND2 SEPTIN9 SLC39A8 MAP3K1 ACAN GNB1 ANKS1A DIP2B SLC25A21 CAMK2G PCDHA7 CPE ZHX2 CRX SUGCT SUSD5 NCOA1 ZFHX3 | 1.69e-03 | 1236 | 246 | 21 | EFO_0004312 |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 1.74e-03 | 103 | 246 | 5 | EFO_0008595, EFO_0020944 | |
| Disease | colorectal cancer, colorectal adenoma | 1.78e-03 | 152 | 246 | 6 | EFO_0005406, MONDO_0005575 | |
| Disease | Bilateral Wilms Tumor | 1.78e-03 | 29 | 246 | 3 | C2930471 | |
| Disease | Chronic pain | 1.88e-03 | 8 | 246 | 2 | HP_0012532 | |
| Disease | sialic acid-binding Ig-like lectin 12 measurement | 1.88e-03 | 8 | 246 | 2 | EFO_0802066 | |
| Disease | gremlin-1 measurement | 1.88e-03 | 8 | 246 | 2 | EFO_0020421 | |
| Disease | lipoprotein measurement | 1.90e-03 | 105 | 246 | 5 | EFO_0004732 | |
| Disease | Malignant neoplasm of prostate | CYP1A1 RNF130 MBTPS1 SAMD9 ARID1A MAP3K1 KMT2C MIF RUNX1 TERT NCOA1 ZFHX3 PCDH8 | 2.14e-03 | 616 | 246 | 13 | C0376358 |
| Disease | Prostatic Neoplasms | CYP1A1 RNF130 MBTPS1 SAMD9 ARID1A MAP3K1 KMT2C MIF RUNX1 TERT NCOA1 ZFHX3 PCDH8 | 2.14e-03 | 616 | 246 | 13 | C0033578 |
| Disease | Coronary Artery Disease | 2.14e-03 | 65 | 246 | 4 | C1956346 | |
| Disease | Coronary Arteriosclerosis | 2.14e-03 | 65 | 246 | 4 | C0010054 | |
| Disease | fear of minor pain measurement | 2.17e-03 | 31 | 246 | 3 | EFO_0008340 | |
| Disease | urate measurement, bone density | SPTLC3 RAP1GAP2 MGLL CFB DOCK5 SEC16A DNAH8 FRAS1 MTHFD1L CAMK2D RUNX1 SEPTIN10 CABIN1 | 2.23e-03 | 619 | 246 | 13 | EFO_0003923, EFO_0004531 |
| Disease | bitter non-alcoholic beverage consumption measurement | 2.37e-03 | 32 | 246 | 3 | EFO_0010093 | |
| Disease | heart conduction disease (implicated_via_orthology) | 2.37e-03 | 32 | 246 | 3 | DOID:10273 (implicated_via_orthology) | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 2.39e-03 | 67 | 246 | 4 | EFO_0008595, EFO_0020946 | |
| Disease | venous thromboembolism, fibrinogen measurement | 2.39e-03 | 67 | 246 | 4 | EFO_0004286, EFO_0004623 | |
| Disease | Acute Confusional Migraine | 2.40e-03 | 9 | 246 | 2 | C0521664 | |
| Disease | Status Migrainosus | 2.40e-03 | 9 | 246 | 2 | C0338489 | |
| Disease | Abdominal Migraine | 2.40e-03 | 9 | 246 | 2 | C0270858 | |
| Disease | Sick Headaches | 2.40e-03 | 9 | 246 | 2 | C0700438 | |
| Disease | Cervical Migraine Syndrome | 2.40e-03 | 9 | 246 | 2 | C0007852 | |
| Disease | tumor necrosis factor ligand superfamily member 14 measurement | 2.40e-03 | 9 | 246 | 2 | EFO_0010613 | |
| Disease | Mental deterioration | 2.40e-03 | 9 | 246 | 2 | C0234985 | |
| Disease | Mild cognitive disorder | 2.40e-03 | 9 | 246 | 2 | C1270972 | |
| Disease | Hemicrania migraine | 2.40e-03 | 9 | 246 | 2 | C0018984 | |
| Disease | mean platelet volume | CYP21A2 KLF3 PSMD2 ANKMY1 ST7L DOCK5 BRD1 ANKS1A NIBAN1 NRF1 KALRN POLR2A DYRK1A DYNC2I1 CHD9 REST RUNX1 TERT | 2.40e-03 | 1020 | 246 | 18 | EFO_0004584 |
| Disease | Seizures | 2.45e-03 | 218 | 246 | 7 | C0036572 | |
| Disease | sexual dimorphism measurement | ARID1A SLC39A8 LIPG KCNH2 ACAN RAB43 PKD1 SEC16A CPNE1 NPAS1 ANKS1A DIP2B POLR2A CXXC5 REST PACS1 SEC11A PAPPA ZFHX3 | 2.47e-03 | 1106 | 246 | 19 | EFO_0021796 |
| Disease | sensorineural hearing loss (is_implicated_in) | 2.60e-03 | 33 | 246 | 3 | DOID:10003 (is_implicated_in) | |
| Disease | Nonorganic psychosis | 2.67e-03 | 69 | 246 | 4 | C0349204 | |
| Disease | serum alanine aminotransferase measurement | GBF1 SEPTIN9 CYP21A2 KLF3 ARID1A SLC39A8 MAP3K1 DDX11 CPNE1 HEPHL1 DIP2B DYRK1A XDH RUNX1 RP1 MX1 | 2.74e-03 | 869 | 246 | 16 | EFO_0004735 |
| Disease | platelet crit | CYP21A2 ADGRV1 ST7L ARID1A TTLL12 LRRN2 PREX1 DIP2B NRF1 KALRN CXXC5 NIBAN2 REST RUNX1 TERT RP1 SORL1 | 2.79e-03 | 952 | 246 | 17 | EFO_0007985 |
| Disease | neutrophil count | TSPAN15 CPAMD8 EYA4 PCDHA9 SEPTIN9 CYP21A2 PSMD2 ARID1A TTLL12 LHX2 PKD1 SFXN2 PREX1 SEMA6C DYRK1A CHD9 PCDHA7 REST TERT NCOA1 RP1 PCNT | 2.93e-03 | 1382 | 246 | 22 | EFO_0004833 |
| Disease | cardiomyopathy (implicated_via_orthology) | 2.96e-03 | 71 | 246 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 2.98e-03 | 10 | 246 | 2 | DOID:13832 (implicated_via_orthology) | |
| Disease | Polydactyly | 3.04e-03 | 117 | 246 | 5 | C0152427 | |
| Disease | migraine disorder | 3.23e-03 | 357 | 246 | 9 | MONDO_0005277 | |
| Disease | Nephroblastoma | 3.34e-03 | 36 | 246 | 3 | C0027708 | |
| Disease | multiple myeloma (is_marker_for) | 3.34e-03 | 36 | 246 | 3 | DOID:9538 (is_marker_for) | |
| Disease | Leukemia, Myelocytic, Acute | 3.39e-03 | 173 | 246 | 6 | C0023467 | |
| Disease | Retinitis pigmentosa | 3.44e-03 | 74 | 246 | 4 | cv:C0035334 | |
| Disease | Rheumatoid Arthritis | 3.49e-03 | 174 | 246 | 6 | C0003873 | |
| Disease | bipolar disorder | ANKS1B SLC39A8 GSDME C12orf76 MMP16 POLR1A NRF1 HUWE1 PEX5L TFAP2B PACS1 CDC25B | 3.52e-03 | 577 | 246 | 12 | MONDO_0004985 |
| Disease | depressive symptom measurement, response to ketamine | 3.62e-03 | 11 | 246 | 2 | EFO_0007006, EFO_0009748 | |
| Disease | Long QT Syndrome | 3.62e-03 | 11 | 246 | 2 | C0023976 | |
| Disease | polybrominated biphenyl measurement, gestational serum measurement, fetal genotype effect measurement, polybrominated diphenyl ether measurement | 3.62e-03 | 11 | 246 | 2 | EFO_0007959, EFO_0007961, EFO_0007962, EFO_0007964 | |
| Disease | Retinal Detachment | 3.62e-03 | 11 | 246 | 2 | C0035305 | |
| Disease | beta thalassemia (is_marker_for) | 3.62e-03 | 11 | 246 | 2 | DOID:12241 (is_marker_for) | |
| Disease | ceramide measurement | 3.71e-03 | 235 | 246 | 7 | EFO_0010222 | |
| Disease | Nonsyndromic genetic hearing loss | 3.78e-03 | 76 | 246 | 4 | cv:C5680182 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GPSLQRTVHDMEQFG | 351 | Q99569 | |
| ASAVSGLMHITGPEN | 186 | Q9HAC7 | |
| DMQESRPAVGLHGET | 306 | Q15361 | |
| LSVQHMSSPGEAVEG | 466 | P43681 | |
| DSIGLEEASGMHLPE | 671 | O95696 | |
| IEDGIHGALSFMTSP | 366 | Q6P093 | |
| AGLAASMAGEHIQLP | 121 | P49189 | |
| VLIDPLAANGTTDMH | 231 | Q9Y6F7 | |
| SFNEVMEAQLPSHGG | 501 | Q8TDY4 | |
| LAFHSAGDAPLQGIM | 1201 | Q9BXX2 | |
| GDQPLERATGEHASM | 451 | Q02641 | |
| PAHGISLFLVENGMK | 226 | P28330 | |
| DSTFLVLMSHGILEG | 201 | P49662 | |
| IVMDSGDGFTHTVPI | 151 | Q9BYX7 | |
| FRTGMLEELHLEPGV | 261 | Q92974 | |
| IDMPDAAHGISSQDG | 266 | O60443 | |
| GTPANVFLMHLAVAD | 91 | Q13304 | |
| PHGIIEFVSDGLIVM | 886 | Q8WXG9 | |
| EEEGMLSPILAHGGV | 41 | Q9BXS5 | |
| GHAIIRTPMGDAVDL | 4776 | Q86UQ4 | |
| AEHAGLFLVMANVDP | 211 | P45954 | |
| MNLVGPQSIEGGAHE | 66 | P05408 | |
| QEGHAVSDMLLPLDG | 61 | Q9BXJ7 | |
| SMQLEETGVHAPGAS | 541 | Q92625 | |
| SLGCILVEMHTGEPL | 346 | Q13627 | |
| LVEMHTGEPLFSGAN | 351 | Q13627 | |
| NHGMGDTSIKFEVVP | 631 | Q8WYQ5 | |
| PTILTEDGMQAQHLG | 426 | Q7Z478 | |
| QIHMPGVGDFAVSDI | 296 | Q14692 | |
| LMQTLEGTPVFVHAG | 666 | Q6UB35 | |
| HAASILVLDGGQPQM | 411 | A6H8M9 | |
| LGHPGMEDVQSVEDA | 171 | Q92481 | |
| FPVDGRVIEGHSMVD | 856 | Q04656 | |
| PEDVVQAEAGGMHTV | 66 | P18754 | |
| ENFDVKHTGPGLLSM | 3146 | P49792 | |
| DPLSGAITVIGHMDF | 296 | Q9Y5H5 | |
| LAEHMLILGITNPEG | 261 | P35558 | |
| VATELIMRHGGPLFS | 176 | Q86YS6 | |
| ISTLQELMAGPGHFN | 171 | P04798 | |
| HPGTGDIIAVMITEL | 146 | Q86XS8 | |
| TFTGEHVVALMPEVG | 121 | Q96MZ0 | |
| FNSMRHEIEGTGLPQ | 41 | Q96TA1 | |
| RVSDHMDLGPSELVG | 321 | Q99742 | |
| APDMQGGHAVLIASE | 816 | Q15334 | |
| GNDFEMSKHPGLLLI | 1996 | O14497 | |
| LHNMGGDPITVIDEI | 391 | P00751 | |
| GSLDVPHIIMQGDAR | 986 | Q7Z6G8 | |
| DPLSGAITVIGHMDF | 296 | Q9UN72 | |
| GSAGLVEICLMHPLD | 21 | Q9BQT8 | |
| GEPHGLENMELRSLE | 101 | Q13127 | |
| EGLSHGIQMEPVDLT | 51 | P57682 | |
| EMLIGQSPFHGQDEE | 571 | Q04759 | |
| ELPDFHVVSNMPGVD | 3786 | Q86XX4 | |
| HVVSNMPGVDGFTLK | 3791 | Q86XX4 | |
| MRTLNHPLGGEFSEA | 2646 | Q8NEZ4 | |
| VFGIELMEVDPIGHL | 161 | P43357 | |
| EMENGIVPTKGIHFS | 271 | Q7Z3D4 | |
| EGIAQGHVMITVASP | 576 | Q14703 | |
| TAAERPGHFAGMVLI | 131 | Q99685 | |
| LLTADGMVHLLPGDE | 296 | A8MXV4 | |
| FLRGMIVIGLETHPA | 196 | Q9Y2Z2 | |
| GNHPKIETAAMDGTL | 4021 | Q07954 | |
| VGPGDFANMLHLKEL | 276 | O75325 | |
| ESDHMAIPGGNQSVL | 371 | O60318 | |
| LGIRISMSHEEEPLG | 71 | Q9Y5P6 | |
| TAMDNHVAGLGPAEE | 216 | Q12809 | |
| MAGAIHFLSDVLGPE | 421 | Q9NS86 | |
| APELLGELHGTFMVV | 311 | Q96Q04 | |
| SDPNHFIIGTDMGLI | 871 | Q8WVS4 | |
| AIPQEVMHGTGDELF | 561 | P52789 | |
| QPSMEEGSGQLLEGH | 266 | P08686 | |
| GLPDMDSSILIHHNG | 221 | Q8N5G2 | |
| PVSAVAALQADGHMI | 396 | Q9ULL4 | |
| PVVNGELTMLGEITH | 206 | Q765P7 | |
| APGTVIGTLAEDLHM | 41 | O95206 | |
| PLGLMAVNQEVSDHG | 326 | P22079 | |
| MIDPDLQTGLGVLFH | 471 | Q8IYB4 | |
| PISQGLFHGAIMESG | 241 | O00748 | |
| LFHGAIMESGVALLP | 246 | O00748 | |
| VGDETMGQLLPHLHE | 1546 | Q96JB1 | |
| GMDVNHGLTELADIP | 641 | Q5GLZ8 | |
| GGLPSEMQDLELAIH | 441 | O60229 | |
| EVTAHLAAAGPVGMA | 66 | Q16656 | |
| SALTVQDVGHVMPGG | 716 | Q9P265 | |
| NPHEAESLALVGAMI | 116 | Q8WVB3 | |
| VGAMIDQVLELHPGA | 126 | Q8WVB3 | |
| FGLSIGIQMPVGHID | 226 | Q9Y5X9 | |
| MIIPAQGHFGISAAT | 236 | P49257 | |
| PLVGLEELEMSGNHF | 216 | Q9HBW1 | |
| TQTMHDLAGLGSETP | 56 | P30305 | |
| LSGPEVHGVIDEMDR | 6 | P50458 | |
| HVVPDQLMAFGGSSE | 41 | P14174 | |
| EALMHLGGIVLNPSF | 536 | Q13219 | |
| EVMQHPSEGGQVLSL | 141 | Q86VP3 | |
| VSPGEVGLFLMGNHT | 896 | Q96FC9 | |
| HVELMELLAAVQSGP | 246 | Q68DD2 | |
| DGIRHVMDGSLPTSL | 526 | Q7Z6Z7 | |
| MAHSAAAVPLGALEQ | 1 | Q8N6N6 | |
| MFLPHENGLSSAEGD | 71 | Q06190 | |
| MPLGAIHLEFQASGN | 661 | Q969R2 | |
| GMSGFDAHTLKEIPQ | 111 | A0A2R8Y4Y8 | |
| GIFTISDHPAEQRGM | 196 | O95613 | |
| VQEHLPLMSEAGAGL | 176 | Q7LFL8 | |
| FKGAAGLHTPVEEDM | 1026 | O75161 | |
| GLHTPVEEDMFHLRG | 1031 | O75161 | |
| GAATTHQLPVAEAML | 716 | Q6VY07 | |
| ILELSGAHSGAPDMS | 1961 | P16112 | |
| LQLHGVDGSPGMLEQ | 91 | Q8N6F8 | |
| MDAVLLEHFPGGLDA | 1 | Q7RTS3 | |
| DTDPELGGAVHLMVV | 426 | Q6ZMV5 | |
| GHQLIITAVVPADMG | 5181 | Q5VST9 | |
| SAILGMHGIFDRPVA | 391 | P36957 | |
| GEDVAVFSKGPMAHL | 456 | P05186 | |
| ALAGGTTMILDHVFP | 96 | O14531 | |
| EDLGAFIPRMQLHEG | 2521 | Q3L8U1 | |
| EMQDLASPHTLVGGG | 31 | O95677 | |
| GMSVLLFLHESPGED | 66 | Q9H5Z6 | |
| APMEGAVQLLSREGH | 51 | Q6TDP4 | |
| GLLNHRPVAMDAGDS | 1726 | Q9Y6J0 | |
| MQEDGRTLPDGTHEL | 511 | Q8N1I0 | |
| VEPSQRMLFNHIGDG | 1731 | Q8N1I0 | |
| PFGVAVMDITDIIHG | 321 | Q9H7D0 | |
| HPDRGMTFNLIGESS | 1806 | P17927 | |
| TGHTGDVMSLSLAPD | 181 | P62873 | |
| VRTAVDQHLGPGAMV | 496 | Q9NVM4 | |
| GLGTANETGVPIMAH | 101 | Q8WW52 | |
| VLSLFPGMIEHGLSD | 221 | Q8NBF6 | |
| PQDTAGMIEIVLGGH | 991 | Q8IZJ3 | |
| IMDIPFVLSANLHGG | 236 | P16870 | |
| TALPEEGGRTALHMA | 651 | Q9P2S6 | |
| TPQFLHMGEIIDGVD | 466 | Q9UHN6 | |
| VGTGEVLLSLDDMHP | 161 | Q6QEF8 | |
| GMLVAEAFEHTPGIQ | 186 | Q9NQR9 | |
| LHSGMLEDGLPSNGV | 51 | Q8WXS3 | |
| MPLVSSGVEHGNLRE | 371 | Q9H9T3 | |
| NLIPILTSGEVFGMH | 146 | Q5I0G3 | |
| VPHGLSATNGEMAEL | 181 | Q9UH90 | |
| EHLELLGPMIHAEVG | 806 | Q6MZM0 | |
| AGVAHMIEALGVLEP | 976 | O75064 | |
| ALIDPTHEGTAEGME | 96 | Q92538 | |
| METGPSLTFIGHQDI | 216 | Q86UT8 | |
| MSHQEGSTGGLPDLV | 1 | A6NGE4 | |
| VGVFLETGDEHPSMN | 146 | P43166 | |
| LDPSRTVFVGALHGM | 426 | Q9BZB8 | |
| SGPITLLVQGHMEGE | 986 | Q05BV3 | |
| TELAGVLPGSLAEHM | 461 | O75155 | |
| TGHGIMEEPELTLIS | 2391 | Q9C0D2 | |
| PMVLDLFGDNHNGLT | 161 | P51168 | |
| IFSGDQIGMLDPHQT | 206 | Q9NZJ4 | |
| LMGEGLAPHLEQITT | 596 | Q8TEX9 | |
| ITPGTDQLGMFTHKE | 231 | Q9BWS9 | |
| LALSGPSVDLMHQAV | 16 | O43186 | |
| EPEALGNLVEGMDFH | 461 | Q13555 | |
| EAMEQLDADGGPLHT | 456 | Q99829 | |
| EPEALGNLVEGMDFH | 381 | Q13557 | |
| MFEGVARVHGSPLEL | 591 | Q9UPQ0 | |
| TLHGQDVLMLPGDLV | 701 | P98161 | |
| DVLMLPGDLVGLQHD | 706 | P98161 | |
| MHVSLAEALEVRGGP | 1 | Q12923 | |
| EFILLGIPHTEGLEM | 11 | Q8NH80 | |
| GIPHTEGLEMTLFVL | 16 | Q8NH80 | |
| NGVLVMHPRNGFTED | 186 | Q96FA3 | |
| FPLKMAHDLDTGSNG | 151 | Q9Y5E3 | |
| GTHSMDLVALAPFGE | 196 | Q6QHF9 | |
| LPGSNMIHGTLQEAD | 1891 | P56715 | |
| IPVKGDGSEMNHLAA | 216 | Q13233 | |
| ELEGLGDIFHPMNAE | 1141 | Q96Q06 | |
| AKVDEFPLGGHMVSD | 41 | Q96L21 | |
| SGDRSMVEVLADHPG | 46 | Q01196 | |
| FSMAHLDGNTEPGLT | 271 | Q6P1K8 | |
| DAEMGARHGLSPLNV | 401 | Q5ST30 | |
| EVVGSSMPLIGDHQD | 386 | P17600 | |
| LHETVALSDIMGAGV | 301 | Q96KT7 | |
| HGSVGDAISVMVPDV | 491 | Q99523 | |
| LGDSPLAFEHVMTRG | 1826 | Q92673 | |
| FPHTILQGRTGLEMG | 146 | O60279 | |
| HTQAMLGLGPEEDKF | 471 | Q684P5 | |
| PLAGLIQDHMVSGAS | 626 | O95602 | |
| SAFHPDTGEKMNVIG | 76 | Q96NB2 | |
| MADADEGFGLAHTPL | 1 | Q99593 | |
| DLNSMIPTHGGDIND | 276 | O94906 | |
| EAPADMGAHQGVAVL | 641 | Q13200 | |
| DMGITHGPAIQIEEL | 56 | Q5K651 | |
| PFIMGIHIIDREHSG | 356 | Q15788 | |
| DGLTTNGVLVMHPAG | 231 | Q8N2H9 | |
| HVPFFSVMLIGGNIE | 2541 | P25391 | |
| FDPNILTIGTGMEEH | 536 | Q99707 | |
| VHSEGQLRSLMPGDF | 256 | A8MTI9 | |
| QLRSLMPGDFHLGDS | 261 | A8MTI9 | |
| GSNVMNDGAPEVLEH | 756 | Q8TCU6 | |
| MKLTVIDTPGFGDHI | 356 | Q9UHD8 | |
| ALHVDPVLNMLVFGE | 211 | Q9Y2E8 | |
| KFVDGLMIHSGDPVN | 151 | P23396 | |
| NMINGTDGDSFHPLI | 246 | Q14108 | |
| ASGMEIGLSSEPHIL | 1731 | Q9UKZ4 | |
| VEELGGHMPRTAETL | 191 | Q9UIF7 | |
| MEDAHTAVVGIPHGL | 36 | O75688 | |
| GLDPHEVDVLMGTFT | 356 | Q9NUV7 | |
| MLALEAAQLDGPHFS | 1 | Q01892 | |
| LTLEPHGDSTEFMGV | 291 | Q9NPQ8 | |
| SILGENPHIGIDMID | 571 | O00327 | |
| VFSVPQMAVPEGDLH | 4871 | Q8IVF2 | |
| QMAVPEGDLHAAVGA | 4876 | Q8IVF2 | |
| HEGTLEPSMIAQSGV | 191 | Q9NPC3 | |
| LLPFATGEHGSMESI | 61 | P42695 | |
| NVMLLPVGSADDGAH | 431 | Q96KP4 | |
| ELEEQSNHAGMGPIL | 81 | Q8N812 | |
| AAETDPGMVHLALGS | 366 | Q9NZN8 | |
| LHETVAPSDIMGAGV | 301 | P0C7Q5 | |
| GGLEMLPQALETHLT | 231 | P50336 | |
| MVDGQPLAEDSGLHI | 2506 | Q63HN8 | |
| LTGPHKLEEGEVAMG | 1221 | Q14690 | |
| DTRLLNEGDLHGMTP | 471 | O75762 | |
| QHPELGVGMTTEGID | 221 | Q8N4P2 | |
| DVAFSVNHLLGDPMA | 46 | O95070 | |
| MASGVEVLRFQLPGH | 1 | Q9Y330 | |
| ALGLEHSNDPTAIMA | 251 | P51512 | |
| MEGELPGEACTLTAH | 811 | Q9BZQ8 | |
| GQPALVEVHSMEALL | 1471 | O15027 | |
| VIHNSTPQFLGMEDG | 121 | Q7Z6I5 | |
| LMDHVFIQPGDLGSG | 841 | Q9UJ98 | |
| LDVMDGHFVPNITFG | 36 | Q2QD12 | |
| QGPTGIHVLISDEMI | 461 | Q12800 | |
| MEDAHTAVIGLPSGL | 36 | P35813 | |
| FSMAHLDGNTEPGLT | 271 | Q13888 | |
| ESHFVPNSLIGMGVL | 56 | P23942 | |
| GPVVSMAGHGEQLFI | 571 | O75717 | |
| ESQIFVISRHGMPLG | 146 | A6NCQ9 | |
| VISRHGMPLGEQDSV | 151 | A6NCQ9 | |
| AHPGEMVGALAAQSL | 1081 | P24928 | |
| DIIMEHSVTDGLLGP | 261 | O95858 | |
| SLAPDSEEHSLGGQM | 1116 | Q6ZT07 | |
| DLMGSVTLDHFGEVP | 1441 | Q9Y2I1 | |
| ALLTQVAVDGMAGPH | 421 | Q9H3T2 | |
| LLHMESQLQDVDPGG | 1426 | Q9H254 | |
| IEQVSVSHLQPLMGG | 111 | Q8TDW4 | |
| VTFPTGVVTNLHGDM | 1641 | Q9P273 | |
| DEDMLITGGRHPFLA | 831 | P47989 | |
| VVLSGSMEPAFHRGD | 51 | P67812 | |
| AGHAPVAVSMADVGL | 1126 | Q86WI1 | |
| EFPGDMELLETLHLG | 1091 | Q9P2J2 | |
| IVPDGSMVILGFHAN | 621 | Q9NNW5 | |
| LTMSGHVGFESLPDQ | 41 | Q9P0V9 | |
| ANLMGIEFHGELPST | 146 | Q14166 | |
| GHGQLDPEMVLSEKA | 221 | A8K0R7 | |
| NGHEAPMTEIKELTG | 106 | P0CJ79 | |
| GVELLQDTLGHVMPS | 231 | Q9Y6X8 | |
| AMHEVARILLGEGPT | 286 | Q9UHR6 | |
| TLSAEGEIVQMHPLG | 91 | Q9ULT6 | |
| PHELGDFVILLNAGM | 346 | Q9C0K1 | |
| GMALPQGHLTFRDVA | 16 | A6NHJ4 | |
| GQLLMVDGRHPDAVA | 71 | Q8NHP8 | |
| MGFLHVGQDGLELPT | 1 | Q9NV72 | |
| SLEMPSGVALEEGAH | 711 | P48553 | |
| EPGIEMLHGTTTLAF | 51 | P28074 | |
| LDVMDGHFVPNITFG | 36 | Q96AT9 | |
| ISGHGMDIALTEPLT | 111 | Q9NX45 | |
| KLVTPHDRMAGFDGS | 321 | P29353 | |
| LAPEIGMQEIALHSG | 1496 | P18583 | |
| DEALGGTAFVQMPAH | 911 | O14746 | |
| REMPTFSGTLEGHLI | 716 | Q9BVV6 | |
| PLFGEIGHTIMNLLV | 1216 | Q7Z3T8 | |
| GPNIVLSEELAGHQM | 151 | Q9H977 | |
| AGHQMPITDIATEPA | 161 | Q9H977 | |
| GDLLAMGDPTLAEDH | 1471 | Q15911 | |
| AGPLEMAQLLITHFG | 51 | P59046 | |
| AGEGMGISHELITLE | 151 | P20591 | |
| QGSMVDERELHPAGT | 256 | O15069 | |
| FMQDPSLVGHTGLDN | 1441 | Q86UW6 | |
| PTSVHGVEDMIRLGD | 61 | Q13402 |